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ABSTRACT 
THE FUNCTION OF PAB1 IN TRANSLATION 
AND IN
PUF3 DEPENDENT DEADENYLATION 
by
Darren J. Lee 
University of New Hampshire, December 2007 
The involvement of the poly(A)-binding protein (PAB1) in deadenylation and 
translation is well known. How PAB1 inhibits deadenylation and promotes translation is 
not well understood. I have analyzed PAB1 variants, containing entire domain deletions 
and substitutions of yeast residues with human residues. Chapter I discusses and 
provides in vivo translation rates of strains containing PAB1 variants, defects in mRNA 
degradation proteins, and defects in translation components. In chapter II, I address the 
role of PAB1 in regulated deadenylation. For this analysis I studied the effect of PUF3, a 
member of the PUF family of proteins that bind specific 3 ’ UTR sequences and 
accelerate deadenylation and/or repress translation of the target transcript.
The analysis of in vivo translation rates, showed that while PAB1 did not have a 
major role in translation, its RRM1 and RRM2 domains were the most important for 
translation. I found defects in translation initiation factors, eIF4E and eIF3, had different 
effects on translation in combination with two PAB1 variants in the RRM2 domain that 
affect different aspects of translation in vitro. CAF1 and CCR4, two components of the 
CCR4-NOT complex responsible for deadenylation, have recently been shown to have 
separate functions in deadenylation. It has been suggested CAF1 and CCR4 have roles in
x
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translation. I show CAF1 and CCR4 do in fact have roles in translation, but as with 
deadenylation, those roles in translation are different.
The mechanism for PUF mediated deadenylation has recently been shown to 
involve recruitment of CCR4 via CAF1, suggesting PUF proteins accelerate 
deadenylation by increasing the local concentration of deadenylases around the mRNA. 
Since PUF proteins are involved in repression of translation it has been suggested that 
they also accelerate deadenylation through perturbation of the mRNP complex. In this 
work I show that PTJF3 requires the PAB1 RRM1 domain for deadenylation of COX17 
mRNA. Additionally, I show that PUF3 bypasses the requirement of the PAB1 P domain 
for deadenylation, and is required for acceleration of deadenylation through defects in the 
cap binding protein, eIF4E. This suggests that PUF3 interacts with PAB1 to disturb the 
mRNP complex to accelerate deadenylation of COX17 mRNA.
xi
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GENERAL INTRODUCTION
Proper and appropriate gene expression is essential to cellular processes ranging 
from following developmental cues to monitoring metabolic activity. Multiple levels of 
control are utilized to obtain proper gene expression. These controls include: promoter 
enhancers and suppressors to regulate transcriptional initiation, chromatin remodeling 
complexes which positively and negatively regulate transcriptional elongation, mRNA 
transcript stability controls the amount of protein that can be translated, various 
translation initiation complexes regulate the translational process, and events such as 
methylation and phosphorylation occur post-translationally to further regulation protein 
function. One area of particular interest is mRNA transcript stability, specifically factors 
contributing to differential transcript stability. Illustrating the wide-range of transcripts 
stability is the stable mRNA transcript, PGK1, which has a 33 minute half-life (Muhlrad 
et al., 1995), and the unstable mRNA transcript, MFA2, which has a 3.5 minute half-life 
(Muhlrad and Parker, 1992). Since the mRNA half-life is directly related to the amount 
of protein that is translated from the mRNA it is important to understand the factors 
contributing to how one mRNA has a longer half-life compared to another mRNA with a 
shorter half-life. Additionally, translationally competent mRNA is absolutely required 
for the translation o f  protein. It is therefore im portant to understand the factors that 
control translation and the factors involved in determining mRNA degradation. 
Furthermore, a link between mRNA degradation and translation initiation has been 
shown (Schwartz and Parker, 1999), which indicates the need to understand the
1
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mechanisms behind both processes. In this dissertation I have focused on two areas: how 
the PUF proteins act to deadenylate COX17 mRNA, and how PAB1 and components 
involved in both mRNA degradation and translation affect translation.
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Figure 1 -  Pathways of eukaryotic mRNA degradation. From Coller and Parker 2004. 
Several pathways of mRNA degradation are known. The major degradation pathway 
requires deadenylation of the poly(A) tail, however, other deadenylation independent 
pathways exist.
3
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mRNA Degradation
The pathways of mRNA degradation can be grouped into two types, 
deadenylation dependent and deadenylation independent (Figure 1). The deadenylation 
dependent pathway is the major mRNA degradation pathway. Degradation of the mRNA 
body occurs following exonucleolytic digestion of the adenines (deadenylation) at the 3’ 
end of the mRNA and decapping of the 5’ 7-meG cap. In yeast, the poly(A) tail is 
initially trimmed by the PAN2/PAN3 complex from 100-110 A’s to 70-90 adenines (A’s) 
(Tucker et al., 2002). The remaining poly(A) tail is digested to approximately 8-12 A’s, 
by the catalytic component of the CCR4-NOT complex, CCR4 (Chen et al., 2002). Next, 
the DCP1/2 complex removes the 5’ cap with the assistance of additional proteins, such 
as DHH1, EDC1, EDC2, LSM1-7, and PAT1 (Dunckley and Parker, 1999; Bouveret et 
al., 2000; Schwartz et al., 2003; Bonnerot et al., 2000; Hilleren and Parker, 1999; He and 
Parker, 1999; Hatfield et al., 1996). Following deadenylation and decapping, XRN1 
then digests the mRNA in the 5’ to 3’ direction (Dahanukar et al., 1999). Also, a multi- 
component complex, called the exosome, can digest the mRNA in the 3 ’ to 5 ’ direction 
following deadenylation (Anderson and Parker, 1998; Mitchell et al., 1997). The 
exosome complex can also digest mRNA, through the nonstop decay pathway, as a result 
of a transcriptional error in which a stop codon has been skipped (Frischmeyer et al., 
2002; Beelman and Parker, 1995). Deadenylation independent mRNA degradation can 
occur through two mechanisms. First, adenylated mRNA can be digested 
endonucleolytically (Binder et al., 1994). Second, a nonsense-mediated decay (NMD) 
pathway degrades mRNA containing a premature stop codon (Muhlrad et al., 1994; Cao 
and Parker, 2001). NMD is thought to have evolved as a surveillance mechanism that
4
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quickly degrades aberrant mRNA containing premature stop codons in order to reduce 
the number of truncated transcripts (Cali and Anderson, 1998). The first step of NMD is 
decapping, followed by XRN1 mediated 5’ to 3’ exonucleolytic decay (Muhlrad and 
Parker, 1994).
Several observations suggest that deadenylation is the rate limiting step of mRNA 
degradation. First, sequences promoting rapid degradation also promote increased 
deadenylation (Decker and Parker, 1993; LaGrandeur and Parker, 1999). Second, stable 
transcripts have a much slower deadenylation rate compared to transcripts that degrade 
rapidly (Decker and Parker, 1993; LaGrandeur and Parker, 1999). Lastly, decapping 
does not occur until the poly(A) tail is approximately 8-12 A’s, which is the minimal 
length of poly(A) that PAB1 can bind (Decker and Parker, 1993; Sachs et al., 1987). 
Since deadenylation is the initial and rate limiting step in mRNA degradation, 
understanding how deadenylation occurs will provide valuable insight into how mRNA 
degradation occurs. CCR4 is of particular interest because it is responsible for the 
majority of deadenylation (Tucker et al., 2001). Further characterization of CCR4 will 
provide valuable information about mRNA degradation. How CCR4 determines which 
mRNA is to be deadenylated more quickly than others is an important area of study.
CCR4
The CCR4 gene was initially identified by Clyde L. Denis in 1984 as a block to 
derepression of the ADH2 gene (Denis, 1984). Subsequent studies revealed that the 
CCR4 protein contains an acidic activation domain at the amino terminus, a leucine rich 
repeat region, and a deadenylase domain (Draper et al., 1994; Malvar et al., 1992). Two 
activation domains present in the N-terminal region were shown to be able to activate
5
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LacZ expression when expressed from a GAL promoter, this shows that CCR4 has some 
role in transcription initiation (Draper et al., 1994). However, deletion of upstream 
ADH2 activation sequences did not affect CCR4 regulation of ADH2 expression, 
indicating that CCR4 is involved in regulating ADH2 expression through mechanisms 
other than simple activation (Denis and Malvar, 1990). The leucine rich repeat region 
was shown to be important in blocking the derepression of ADH2 (Malvar et al., 1992). 
However, since CCR4 is part of a multi-protein complex called the CCR4-NOT complex 
and the LRR was shown to be important in contacting additional proteins in the CCR4- 
NOT complex (Clark et al., 2004; Draper et al., 1994; Ohn et al., 2007) the function of 
the LRR in ADH2 expression may be to simply contact the remainder of the complex. 
Initially, the major role of CCR4 was thought to be in transcription initiation, whereby 
the CCR4 activation domain was thought to play a part in transcription initiation and the 
leucine rich repeat region was utilized to contact additional proteins involved in proper 
promoter placement (Draper et al., 1994). Until recently, the C-terminal exonuclease 
domain was largely unexplored, but in 2001 CCR4 was discovered to be responsible for 
the majority of mRNA deadenylation in the cell (Chen et al., 2002; Tucker et al., 2001).
Additional components of the CCR4-NOT complex are CAF1, NOT1-5, CAF40, 
and CAF130 (Chen et al., 2001). NOT1 serves as a scaffold for the CCR4-NOT 
complex; CAF1, CAF40, CAF130 and the remaining NOTs all bind to NOT1 (Chen et 
al., 2001). CAF1 acts as a bridge between CCR4 isolating it from the rest of the complex 
(Bai et al., 1999). The NOTs were identified in a screen for genes capable of bypassing a 
delta insertion in the HIS3 promoter, which indicates that they have a role in
6
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transcriptional initiation (Collart and Struhl, 1994; Collart and Struhl, 1993; Viswanathan 
et al., 2004). NOT5 and NOT3 contact TFIID (Collart and Struhl, 1994; Lemaire and 
Collart, 2000) and NOT4 appears to have ubiquitin ligase activity (Irie et al., 1994;
Albert et al., 2002) and a putative RNA binding motif. Genetic evidence also suggests 
the involvement of the CCR4-NOT complex in transcriptional elongation (Denis et al.,
2001). Currently, CAF40 and CAF130 remain largely uncharacterized. What is also not 
well understood is how the CCR4-NOT complex components work together to affect 
deadenylation and how the rates of mRNA deadenylation are regulated. In particular, the 
mechanism whereby CCR4 targets specific mRNA for faster or slower deadenylation 
remains to be elucidated.
It has been shown that certain mRNA binding proteins, such as the PUF family of 
proteins, act on specific target mRNA to suppress translation and activate deadenylation 
(Crittenden et al., 2003; Olivas and Parker, 2000; Edwards et al., 2001; Wang et al.,
2002; Wang et al., 2001; Crittenden et al., 2002). Furthermore, it has been shown that 
PUF3 and PUF5 interact with or require CCR4 to deadenylate mRNA (Olivas and Parker, 
2000; Goldstrohm et al., 2007; Goldstrohm et al., 2006; Tucker et al., 2002; unpublished 
data). How CCR4 works in concert with the PUF proteins is a particular area of interest. 
CCR4 could work by a simple recruitment model, whereby RNA binding proteins, such 
as the PUFs, bind specific mRNAs to bring them in contact with the deadenylase (Figure 
2A). Another model suggests that factors causing mRNP disruption or rearrangement 
could result in the stalling of translation initiation which could also allow degradatory 
proteins access to the mRNA (Figure 2B). These models have been hypothesized to 
explain how the PUF proteins work to suppress mRNA.
7
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Figure 2A -  Recruitment model of mRNA deadenylation. A consensus sequence located in the 3’ 
UTR is bound by PUF3 which in turn binds mRNA degradation proteins. mRNA degradation is 
accelerated by increasing the local concentration of mRNA degradation proteins around the 




Figure 2B -  mRNP disruption model of mRNA deadenylation. PUF3 binds the consensus 
sequence located in the 3’ UTR. Through PUF3 interaction with mRNP components, disruption 




Figure 2C -  Simultaneous recruitment and mRNP disruption model of mRNA deadenylation. 
PUF3 causes PAB1 dissociation from poly(A) and recruits mRNA degradation components.
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PUF Family of Proteins
The PUF protein family members all share a conserved RNA binding domain
capable of recognizing a consensus repeat consisting of four core ribonucleotides,
UGUR. The PUF name is derived from the two proteins first characterized; Pumilio, in 
Drosophila melanogaster and FBF, found in Caenorhabitis elegans. The PUF family of 
proteins consists of at least four subfamilies (Spassov and Jurecic, 2003). The following 
PUM family members share 49% sequence identity: Pumilio in Drosophila, Puf 8 and 9 
in C. elegans, and PUM1 and PUM2 in mammals. The FBF subfamily shares -20% 
sequence identity to the PUM family and its members consist of seven proteins found in 
C. elegans and the PUF5 protein found in Saccharomyces cerevisiae. Another subfamily 
sharing more similarity to PUM than FBF contains the PUF proteins found in plants and 
PUF3 and PUF4 from yeast. The last subfamily with very distant sequence similarity 
consists of the yeast proteins PUF1, PUF2, and PUF6.
Crystallography and mutational studies showed that the RNA binding domain of 
the Pum protein in Drosophila forms a crescent in which hb mRNA binds to conserved 
residues on the inner surface, whereas Nos and Brat bind to the outer surface along the 
eighth repeat (Edwards et al., 2001; Wang et al., 2001; Muhlrad and Parker, 1999). 
Strikingly, this C-terminal region has 78% and 79% sequence similarity to the 
mammalian PUM1 and PUM2 genes (Spassov and Jurecic, 2002). This observation 
suggests that the RNA binding region is the most important for function.
In  the eukaryotes that PU F proteins have been identified, the biological roles are 
very diverse. These roles range from stem cell maintenance, the mating switch in yeast
9
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and worm, embryological development, and a mitochondrial role. Clearly, PUF proteins 
have various biologically important roles which will be addressed further.
Puml and Pum2 are highly expressed in mouse fetal and adult hematopoietic stem 
cells (Spassov and Jurecic, 2003) and PUM2 is expressed in human germline cells 
(Nakahata et al., 2003). This is suggestive of a mammalian role for PUM in stem cells.
The FBF protein in C. elegans is responsible for translational repression of gld-1 
mRNA, which prevents germline cell differentiation allowing for stem cell proliferation 
(Crittenden et al., 2003; Crittenden et al., 2002). FBF is highly expressed in germline 
stem cells and fbf-Hfbf-2 mutants do not have germline stem cells (Crittenden et al.,
2002). Another mRNA that FBF acts on is fem-3, which is involved in the sperm/oocyte 
switch (Kraemer et al., 1999). The FBF protein in C. elegans works with NANOS-3 to 
accomplish translational repression offem-3 mRNA (Kraemer et al., 1999), and represses 
expression of gld-1 mRNA (Crittenden et al., 2002).
Drosophila is another system that may have a Pum involvement in stem cells.
Pum is highly expressed in germline stem cells and pum -/- stem cells undergo 
uncontrolled differentiation (Lin and Spradling, 1997). Pumilio (Pum) plays a role in 
establishing a hunchback (hb) protein gradient in the developing Drosophila embryo 
necessary for proper abdominal segmentation (Murata and Wharton, 1995; Wreden et al.,
1997). A 32 ribonucleotide sequence called the Nanos recognition element (NRE) is 
recognized by Pum. Translational repression and deadenylation of hb occurs when Pum 
binds the NRE located in the 3’ UTR. It is important to note that Pum cannot accomplish 
this suppression of hb without the proteins Nanos (Nos) and Brain Tumor (Brat)
(Edwards et al., 2001; Wang et al., 2002; Wang et al., 2001; van Hoof et al., 2000).
10
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Recognition of the hb NRE is accomplished independently of Nos and Brat and 
complementation of a pum mutant is possible by Pum repeats alone (Wharton et al.,
1998).
In Saccharomyces, deadenylation of COX17 mRNA is dependent on PUF3 and 
the PUF recognition sequence in the 3’UTR is essential for PUF3 mediated deadenylation 
(Olivas and Parker, 2000; Jackson et al., 2004). Mutation analysis of PUF3 has indicated 
that the outer surface is important for deadenylation of COX17 mRNA (Houshmandi and 
Olivas, 2005) suggesting that contact with additional proteins is important for 
deadenylation. Another PUF protein in Saccharomyces, PUF5, is required for 
deadenylation of HO mRNA (Goldstrohm et al., 2007). The 3’UTR of HO has also been 
shown to confer translational suppression when fused to the ADE gene (Tadauchi et al., 
2001). These results show that in yeast, both PUF3 and PUF5 suppress expression of 
their target mRNA transcripts through acceleration of the deadenylation rate, and PUF5 is 
capable of translation suppression of a chimeric mRNA. This indicates that PUF in yeast 
is a suitable model for analyzing PUF function and is likely to exploit similar 
mechanisms of action as those used in higher eukaryotes.
At the molecular level, PUF proteins are involved in proper protein expression at 
a post-transcriptional level. It has been shown that PUF proteins are capable of 
suppressing translation of specific mRNAs and promoting the deadenylation of target 
mRNAs. The precise mechanism explaining how deadenylation is stimulated by the PUF 
proteins remains to be discovered. Additionally, the mechanism whereby PUF proteins 
suppress translation remains to be determined. Two models describing how PUF proteins 
suppress expression are the recruitment model and mRNP disruption model.
11
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As described in the recruitment and mRNP disruption models in the CCR4 section 
above, PUF proteins could act by contacting specific mRNA and mRNA degradatory 
proteins thereby recruiting the degradatory proteins to specific mRNA or PUF could act 
by contacting components of the mRNP complex thereby causing them to dissociate from 
the mRNA allowing degradatory proteins access to the mRNA. A third model could be 
envisioned which combines the recruitment model and mRNP disruption model (Figure 
lc). PUF proteins could cause mRNP destabilization or rearrangement and 
simultaneously bring mRNA degradation proteins to the mRNA. The mRNP disruption 
model does provide a mechanism for the translational suppression caused by PUF 
proteins. However, since translation initiation and mRNA deadenylation are linked 
(Schwartz and Parker, 1999), it is possible that both models are correct. In order to 
obtain more information for either model the proteins involved in translation need to be 
further characterized. Information about the translational involvement of proteins 
involved in mRNA degradation and components of the mRNP complex would shed more 
light on how translation occurs, and specifically, prove or disprove the mRNP disruption 
model.
CAF1
CCR4 associated factor (CAF1) was first identified in a screen for overproduction 
of the mammalian a-amylase driven by a PGK promoter (Sakai et al., 1992). This gene 
was termed PGK promoter overproduction, or POP2. POP2 was the first term for this 
gene, but due to the association with CCR41 will refer to it as CAF1. Additional 
phenotypes of the cafl allele are: a block in glucose derepression, temperature sensitivity, 
sporulation defects, and reduced carbohydrate reserves.
12
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In the CCR4-N0T complex, CAF1 is the primary contact between CCR4 and the 
NOT proteins (Bai et al., 1999). CAF1, being an RNase of the DEDD superfamily, has 
deadenylase activity (Daugeron et al., 2001) and is required for deadenylase activity in 
vivo (Tucker et al., 2001; Daugeron et al., 2001). However, mutations in the RNaseD 
domain of CAF1 did not affect in vivo deadenylation activity (Viswanathan et al., 2004), 
and a lesion in CCR4 caused a more severe block in deadenylation (Tucker et al., 2001). 
This also suggests another role for CAF1, as the CCR4 protein is responsible for the 
majority of cytoplasmic deadenylase activity (Tucker et al., 2002). Mutation of CAF1 
residues important for CCR4 contact were shown to cause deadenylation defects, further 
indicating CAF1 has a separate role in deadenylation from CCR4 (Ohn et al., 2007). 
Clearly, the exact role of CAF1 in mRNA deadenylation is unknown and further study of 
this protein is necessary to determine its precise function.
A translational role for CAF1 has been suggested through two observations. First, 
a cafl deletion displayed a synthetic lethality with PAB1-ARRM2 which can be rescued 
by over-expression of STM1 and DHH1 (Ohn et al., 2007). STM1 has a role in 
translation and makes contact with the ribosome (Van Dyke et al., 2006; Van Dyke et al., 
2004) and DHH1 has role in both decapping and translation (Coller et al., 2001; 
Ladomery et al., 1997; Nakamura et al., 2001; Navarro et al., 2001). Second, over­
expression of CAF1 rescues the lethality observed in a cdc33-l strain, which has defects 
in the translation initiation factor eIF4E (Ohn et al., 2007). For the purpose of 
determining if CAF1 has a role in translation and what that role is, I have measured in 
vivo translation rates in a cafl A strain in combination with the cdc33-l allele and PAB1- 
RRM2 variants, and over-expressed CAP I in a strain carrying the cdc33-l allele.
13
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Translation
Translation describes a process resulting in the conversion of mRNA into protein. 
In all eukaryotes the 80S ribosome is responsible for translation. The 80S ribosome can 
be divided into the two core components, the 40S and 60S ribosomes. Ribosomes are 
composed of many proteins and several RNA. In yeast, all ribosomal proteins also have 
a homolog in mammalian systems (Mager et al., 1997), so translation in yeast is probably 
representative of translation in mammals. The yeast 60S ribosome is composed of 42 
ribosomal proteins and three RNAs: 5S (121 nt), 5.8S (158 nt), and 25S (3392 nt). The 
smaller 40S ribosome consists of 32 proteins and a 18s RNA (1798 nt). By weight, the 
majority of the ribosome is RNA, compared to protein. In the 60S ribosome, the RNA to 
protein ratio is -61% to 39%, and the 40S subunit has a 54% RNA to 46% protein ratio 
(Verschoor et al., 1998).
Translation begins with the formation of the 43 S complex, which occurs when 
eIF2-GTP- Met-tRNAjMet binds the 40S ribosomal subunit. This process is facilitated by 
the translation initiation factors, eIF3, elFl, and elFlA (Figure 3A). Binding of the 43S 
complex with the mRNP complex through eIF4G occurs in mammals through eIF3, but 
in yeast it is thought that eIF2 bridges the eIF4G-eIF3 interaction. When the 43 S 
complex binds the mRNP complex the pre-initiation complex is formed, also called the 
48S complex (Figure 3B). Hydrolysis of eIF2-GTP to eIF2-GDP occurs when the 48S 
complex locates the AUG start codon. Dissociation of eIF3, elFl, elFl A, and eIF2 
occurs following eIF2-GTP hydrolysis (Figure 3C). Following dissociation of eIF3, 
elFl, elFlA, and eIF2 the 60S ribosomal subunit binds the 40S ribosomal subunit 
forming the 80S ribosome (Figure 3D).
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Figure 3A -  Formation of the 43S ternary complex. 
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Figure 3B -  Formation of the 48S preinitiation complex
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Figure 3C -  Hydrolysis of elF2-GTP to elF2-GDP causes dissociation of elF2, elF1, elF1A, and 





Figure 3D -  Formation of the 80S ribosome.
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Translational elongation of the polypeptide occurs through hydrolysis of GTP by 
eEFl A when an aminoacyl-tRNA of the correct anti codon is brought to the A site of the 
ribosome. Peptidyltransferase then catalyzes a peptide bond with the amino group of the 
peptide in the P site. This process continues until a stop codon is reached. A stop codon 
(UAA, UGA, or UAG) is recognized by eRFl (Frolova et al., 1994), and 
peptidyltransferase catalyzes a bond to water instead of an aminoacyl-tRNA.
Dissociation of the complete polypeptide, 40S, and 60S ribosomal subunits from the 
mRNA occurs through the hydrolysis of GTP by eRF3 (Zhouravleva et al., 1995).
Deletion of the N terminal region of eRF3, which is the region responsible for 
contacting PAB1, blocks PAN2/3 deadenylation but also appears to affect CCR4 
dependent deadenylation (Hosoda et al., 2003). Mutation of the GTP binding motif in the 
C-terminal region of eRF3 is required for association with eRFl and increases mRNA 
degradation rates (Kobayashi et al., 2004). These last two observations link translational 
termination with mRNA deadenylation.
In mammals, regulatory proteins, called 4E-binding proteins (4E-BPs) bind to 
eIF4E. 4E-BPs blocks eIF4E contact to eIF4G which results in a block in translation.
The only 4E-BP in yeast is p20 (CAF20) which has been shown to competitively bind to 
eIF4E and cause the similarly observed block in cap-dependent translation, as in 
mammalian cells (Ptushkina et al., 1998). Over-expressed CAF20 displayed synthetic 
lethality in backgrounds containing defect in eif-4e, eif-4a, eif-4, and eif-4g (de la Cruz et 
al., 1997), further indicating a CAF20 role in translation initiation. One model suggests 
that CAF20 inhibits translation by disrupting the mRNP complex. By over-expressing 
CAF20 we can determine how perturbations in the mRNP structure affect translation.
17
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Another method to determine how the mRNP structure affects translation is by analyzing 
defects in components of the mRNP structure. One such mRNP component suitable for 
analysis is the poly(A)-binding protein, or PAB1.
PAB1
Initial identification of PAB1 in rabbit and mouse was through association with 
the polysome (Blobel, 1972). In subsequent studies upon isolating PABP or PAB1 
(poly(A) binding protein), it was shown to bind to the 3’ poly(A) tail of mRNA (Blobel, 
1973). The PAB1 protein has four RNA Recognition Motifs (RRM1-4), an unstructured 
Proline and Methionine rich region (P), and a globular C-terminal region (C). Contact 
between eIF4G and PAB1 is made through RRM2, and the C terminal region makes 
multiple protein contacts with: PBP1, eRF3, and the deadenylase PAN2/3 ((Hosoda et al., 
2003; Mangus et al., 2004; Mangus et al., 1998). A mature mRNA available for 
translation is bound by multiple proteins into a complex called the mRNP complex. The 
core components of the mRNP complex are eIF4E which contacts the 5’ cap of the 
mRNA, PAB1 which binds the 3’ poly (A) tail, and eIF4G, which contacts PAB1 and 
eIF4E causing the mRNA to form a loop (Wells et al., 1998; Jacobson and Peltz, 1996; 
von Der Haar et al., 2000).
Since PAB1 is bound to mature mRNA in the cytoplasm, it is highly suggestive 
that PAB1 plays a role in stability of the mRNA and/or translation of mRNA into protein. 
One class of mutations allowing for viability of a pabl deletion are mutations in mRNA 
degradation factors (Caponigro and Parker, 1995), suggesting a role for PAB1 in mRNA 
degradation. Additionally, in vitro evidence showed PAB1 to inhibit mRNA 
deadenylation (Tucker et al., 2002; Wilusz et al., 2001). However, in vivo, a pabl
18
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deletion resulted in mRNA with long poly(A) tails, suggesting that PAB1 has multiple 
roles in deadenylation of mRNA (Caponigro and Parker, 1995). Since PAB1 has been 
shown to play a role in mRNA biogenesis (Dunn et al., 2005), proper export of mRNA 
from the nucleus (Brune et al., 2005), and adenylation of the 3’ end of mRNA (Dheur et 
al., 2005), the inconsistency between the in vivo and in vitro observations could be due to 
epistatic effects the pabl deletion has on mRNA other than specific degradation of the 
mRNA transcript. Alternatively, it has been suggested, that in a pabl deletion, non­
specific RNA binding proteins associated with the poly(A) tail inhibit deadenylation.
The role of PAB1 in deadenylation is most likely an inhibitory one in terms of CCR4 
action but it is also required for deadenylation.
Recent analysis of PAB1 has suggested a model whereby PAB1 self-association 
results in reduced poly(A) binding, thereby accelerating deadenylation (Yao et al., 2007). 
The model of PAB1 self-association to promote deadenylation is supported through three 
observations. First, the two PAB1 domain deletions resulting in the most severe defect in 
deadenylation are PAB1-ARRM1 and PAB1-AP (Yao et al., 2007). Second, these PAB1 
domains are also necessary for the self-association or circularization of PAB1. Third, the 
self-associated PAB1 binds poly(A) less efficiently compared to linear PAB1 (Yao et al., 
2007). This model indicates that PAB1 has an inhibitory role in deadenylation, and when 
it dissociates from the poly(A), through self-association, deadenylation occurs. If PAB1 
works through a general mechanism to inhibit all mRNA, then analysis of PAB1-ARRM1 
and PAB1-AP should show a defect in deadenylation for a PUF3 controlled mRNA such 
as COX17.
19
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Another class of mutations allowing for the viability of a pabl deletion are 
defects in translational components, suggesting a PAB1 role in translation (Sachs and 
Davis, 1989). It has been shown that deletion of RRM2 and RRM4 in PAB1 cause 
decreased in vitro translation (Kessler and Sachs, 1998), furthermore substitution of 
PAB1 RRM2 yeast residues with human residues showed defects in in vitro translation 
(Otero et al., 1999). Tethering various PAB1 domains to a luceriferase-MS2 fusion 
transcript has shown, in vivo, that specific regions of PAB1 are capable of stimulating 
translation (Gray et al., 2000). Clearly, further analysis of PAB1 is necessary to 
determine the exact role that it has on mRNA stability and translation.
One way to determine the function of PAB1 is to conduct a deletion analysis of 
the protein. In order to understand the effect of mRNA binding, point mutations 
abrogating the mRNA binding ability were created (Sachs and Deardorff, 1992). By 
changing the order of the domains we were also able to gain insight into any positional 
effects and possible linker interactions between the domains. Lastly, swaps between 
human PABP1 domains and yeast PAB1 domains have been constructed in order to 
determine which human residues have a different function in yeast. These PAB1 variants 
were analyzed to determine additional information about how PAB1 involvement in 
deadenylation and translation occurs.
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CHAPTER I
MEASUREMENT OF IN  VIVO TRANSLATION RATES IN STRAINS CONTAINING 
PAB1 VARIANTS, DEFECTS IN mRNA DEGRADATION COMPONENTS, AND 
DEFECTS IN TRANSLATION COMPONENTS
Introduction
Gene regulation at the level of translation initiation is a very complex process. By 
determining the exact mechanisms whereby translation occurs we hope to better 
understand how the process is regulated. As reviewed in Sonenberg, 2003; Sachs et al., 
1997 (Sachs et al., 1997; Sonenberg and Dever, 2003), translation begins with 
recruitment of the eIF2-GTP- Met-tRNA,Mct complex to the 40S ribosome, this is 
facilitated by eIF3, elFl, and elFlA, thus forming the 43S complex (Figure 3A). The 
48S complex forms when the 43S complex binds eIF4F, mRNA, and PAB1 (Figure 3B). 
The 48S preinitiation complex then locates the AUG start codon which causes the 
hydrolysis of eIF2-GTP to eIF2-GDP (Figure 3C). Hydrolysis of eIF2-GTP to eIF2-GDP 
causes eIF2 to dissociate from the ribosome, followed by dissociation of the remaining 
elFs (Figure 3C). After dissociation of all elFs from the ribosome, binding of the 40S 
and 60S ribosomes occurs, resulting in a translationally competent 80S ribosome (Figure 
3D).
It is known that the cap structure and the poly(A) structure have a synergistic 
relationship which allows for efficient translation (Otero et al., 1999). In order to
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determine how the cap and poIy(A) structure function in translation we must analyze the 
proteins associated with these structures. The most suitable candidates for analysis are 
the core components of the mRNP complex: eIF4E, eIF4G, PAB1 (Jacobson A. and Peltz 
S.W., 1996; von Der Haar T. et al., 2000). eIF4E and eIF4G both play a role in cap- 
dependent translation (Otero et al., 1999; Gross et al., 2003). However, eIF4G may 
present a greater challenge due to the fact that two genes encode it, making it more 
complicated for gene deletion analysis. As such, the temperature sensitive (ts) eIF4E 
protein which is encoded by the cdc33-l allele may be more useful in understanding cap- 
dependent translation. PAB1 is known to play a role in both cap-dependent and poly(A) 
dependent translation (Otero et al., 1999). In order to better understand cap-dependent 
and poly(A) dependent mechanisms we have to understand the role that PAB1 has in 
translation. PAB1 variants can be analyzed alone and in combination with the eIF4E 
defect for the purpose of gaining additional insight into the function of PAB1 in 
translation. By combining mutations in these two genes (eIF4E and PAB1) we provide a 
system in which cap-dependent and poly(A) dependent translation are both defective, 
thereby allowing us to better understand how these mechanisms operate to carry out the 
translational process.
In order to gain additional insight into the role of PAB1 on translation analysis of 
PAB1 defects with another translational defect other than eIF4E may be useful. A 
temperature sensitive (ts) allele of eIF3 (encoded by prtl-63) is a particularly useful 
strain because it represents a defect at a different site in translation than eIF4E. 
Additionally, this allele has been previously studied by Schwartz and Parker (Schwartz
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and Parker, 1999): in the same procedure that I used to measure translation rates. The 
eIF3 complex is involved in the joining step between the mRNP complex, ribosome, and 
eIF2-GTP- Met-tRNAjMet (Jivotovskaya et al., 2006), which occurs before contact with 
eIF4G is made. Additional evidence suggesting that eIF3 and eIF4G have different roles 
in translation is supported by the observation that depleting eIF3 does not allow mRNA 
accumulation on ribosomes, whereas depletion of eIF4G results in mRNA bound to 
ribosomes but has defects in the 60S ribosomal subunit joining step (Jivotovskaya et al.,
2006).
The PAB1 domains seem to have discrete functions in translation, as suggested by 
three observations. First, Sachs and colleagues has shown that RRM2 is involved in 
contacting eIF4G, (Otero et al., 1999) which is also a core component of the mRNP 
complex (Jacobson A. and Peltz S.W., 1996; von Der Haar T. et al., 2000; Wells et al.,
1998). The fact that the PAB1 RRM2 domain contacts eIF4G and that PAB1 RRM1 is 
not directly involved in eIF4G contact while still having a role in translation suggests 
PAB1 RRM1 and PAB1 RRM2 each have different roles in translation. Second, each of 
the PAB1 RRMs have varying mRNA binding specificities and translational involvement 
(Burd et al., 1991), also indicating a modular nature to the PAB1 protein. Third, 
sequence similarity between domains RRM1-RRM4 within PAB1 (in yeast 25-43%) is 
much lower than across species (61% amongst the PAB1 RRM1 domain; 64% amongst 
the PAB1 RRM2 domain; 55 % for PAB1 RRM3 domain; 77% for PAB1 RRM4), 
suggesting discrete conserved functions among the individual domains. Since deletion of 
PAB1 is lethal and the various domains seem to serve different functions from one 
another, analysis of the PAB1 protein containing a deletion of each domain is one way to
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better understand the function of the individual PAB1 domains and hence how the PAB1 
protein functions.
Another method to determine the function of PAB1 in translation would be to 
analyze the ability of each domain to stimulate translation, as performed by Wickens and 
colleagues (Gray et al., 2000). Determination of PAB1 domains capable of stimulating 
translational activity was done by injecting Xenopus laevis oocytes with a luciferase RNA 
reporter containing a MS2 binding site and a fusion protein containing a PAB1 variant 
fused to the MS2 protein (Gray et al., 2000). The MS2 protein recognizes and binds the 
MS2 RNA binding site in the luciferase RNA (Withered et al., 1991), thus tethering the 
PAB1 variant to the luciferase RNA. This analysis determined which portions of PAB1 
are capable of simulating translation, thus implicating those portions of PAB1 that are 
involved in translation. If the identified portions of PAB1 are necessary for translation 
then deletion of those domains should show a decreased translational rate in vivo and in 
vitro, and PAB1 regions incapable of translation stimulation should not show any effect 
on the translation rate. In vitro analysis of PAB1 domain deletions has been conducted 
(Otero et al., 1999; Kessler and Sachs, 1998) and some results agree with the oocyte data, 
but some results do not. Another analysis of PAB1 would help clarify what exactly the 
role of PAB1 is with respect to translation. Using a set of PAB1 domain deletions I have 
measured the in vivo translation rates in order to gain additional insight into the role of 
eachPABl domain.
Other factors may also affect translation, including the proteins involved in 
shortening the poly(A) tail, such as the CCR4-NOT deadenylase complex. Specifically, 
CAF1 may play a role in aiding translation and can be surmised through three
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observations. First, lethality between a PAB1-ARRM2 and caflA has been observed (Ohn 
et al. 2007), indicating a genetic interaction between a core component of the mRNP 
complex, PAB1, and that of CAF1. Second, a screen for genes whose over expression 
was capable of bypassing the lethality of the PAB1-ARRM2 caflA double mutant 
identified the following genes: DHH1, STM1, SEC66, MSP1, OKP1, and POL4 (Ohn et 
al. 2007). Homologs of DHH1 are involved in translational suppression (Ladomery et 
al., 1997; Nakamura et al., 2001; Navarro et al., 2001), and STM1 contacts ribosomes and 
is involved in translation following nitrogen starvation (Van Dyke et al., 2006; Van Dyke 
et al., 2004). Because DHH1 and STM1 are capable of rescuing the PAB1-ARRM2 caflA 
lethality and are involved in translation, this implies that a role for CAF1 in translation is 
possible. Third, the cdc33-l allele, encoding a defect in eIF4E is lethal at 37°C, can be 
rescued by over-expression of CAF1 (Ohn et al 2007).
In addition to CAF1, another member of the CCR4-NOT complex that may have 
a role in translation is CCR4. There are four observations that suggest CCR4 
involvement in translation. First, a link between mRNA deadenylation and translation 
termination has been observed (Keeling et al., 2006). Second, the stress response slows 
deadenylation and suppresses translation, which suggests a link between link between 
deadenylation and translation (Hilgers et al., 2006). Third, deletion of the N terminal 
region of eRF3 blocks deadenylation and interferes with translation termination (Hosoda 
et al., 2003). Lastly, mutation of the GTP binding motif in the C-terminal region of eRF3 
is required for association with eRFl and increases mRNA degradation rates (Kobayashi 
et al., 2004). Since, the role of CAF1 seems to be more closely linked to CCR4 than 
with the rest of the CCR4-NOT complex, CAF1 may have multiple roles, as with CCR4,
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one in deadenylation and another in translation. What is not well understood is how 
CAF1 operates in translation and in deadenylation.
In order to show more definitively that CAF1 and CCR4 are involved in 
translation and to help understand the role of each protein in translation, I have conducted 
in vivo translation assays in caflA, ccr4A, alone and combined with cdc33-l, and also in 
a cdc33-l background with over-expressed CAF1 and CCR4. In vivo translation rates 
have also been measured in strains with defects in other mRNA degradatory proteins, 
such as DCP1, DHH1, and PAN3. In order to better understand the relationship between 
CAF1 and the RRM2 domain of PAB1, rates have been measured in RRM2 mutants 
capable of rescuing the synthetic lethality combined with caflA mutants. For the 
purpose of determining what the translational role of PAB1 is and how the interaction 
between PAB1 with additional factors affects translation, I measured the translation rates 
of the PAB1 variants combined with prtl-63, cdc33-l, ccr4A, and caflA.
Materials and Methods 
Yeast Strains and Plasmids
Yeast strains are shown in Table 1. Plasmids used are shown in Table 2. Yeast 
cells were inoculated into YEP medium (1% Bacto-yeast extract, 2% Bacto-peptone) 
containing 2% glucose, and grown to exponential phase.
35S In Vivo Translation
In vivo translation was done in a similar fashion as previously described 
(Schwartz and Parker, 1999). Five mL yeast cells were grown to exponential phase in 
2% glucose YEP medium, the optical density at 600 nm was measured, then cells were 
pelleted and resuspended in prewarmed 37°C met' medium (0.67% yeast nitrogen base
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without amino acids, and amino acids as required except methionine). Twenty five pCi 
[35S] labeled methionine was then added to the resuspended cells in met' medium. At 10 
and 20 minute time points, cold 10% trichloroacetic acid (TCA) was added to the 
reaction, incubated for five minutes at 95 °C, and precipitated proteins were then 
collected on nitrocellulose membrane filters. Filters were then washed with 10 mL 5% 
TCA, and finally with 10 mL 70% ethanol. Following washing, filters were dried for 30 
minutes, [35S] incorporation into protein was then measured in a liquid scintillation 
counter. Using the Excel program, incorporated [35S] per optical density was determined 
by dividing counts by the optical density for the strain. Rates were measured by dividing 
the [35S] per optical density difference between time points by the difference between the 
time points. Standard error of the mean (SEM) was used to determine if the rates were 
significantly different. SEM was calculated by dividing the standard deviation by the 
square root of the total number of samples.
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Table 1 Yeast Strains Used
Strain Relevant Genotype Source
AS31 QlpYC360 a ade2 his3 Ieu2 trp1 ura3 pab1::HIS3 [PAB1-URA3] Yao et al., 2007
AS319 lpYC504 Isogenic to AS319/360 except [PAB1-TRP1] Yao et al., 2007
AS 188 MpYC504 Isogenic to AS319/360 except [PAB1-TRP1] cdc33-1 Ohn et al., 2007
1743-2/p YC504 75% Isogenic to AS319/360 except [PAB1-TRP1] prt1-63 C. Denis, UNH
1729-3/p YC504 75% Isogenic to AS319/360 except [PAB1-TRP1] gst1-1 C. Denis, UNH
AS319-1 a-uN/p YC504 Isogenic to AS319/360 except [PAB1-TRP1] ccr4::ura3::NEO
Yao et al., 
2007
AS319-c1 -\WpYC504 Isogenic to AS319/360 except [PAB1-TRP1] caf1 ::ura3::LEU2




Isogenic to AS319/360 except [PAB1-TRP1] 
dhh1::ura3::LEU2
Hata et al., 
1998
DB267lpYC504 Isogenic to AS319/360 except [PAB1-TRP1] pan3A Yao et al., 2007
1754-1-tN lpYC504 Isogenic to AS319/360 except [PAB1-TRP1] pan2::trp1::NEO
Yao et al., 
2007
Strains were obtained from various sources as indicated by the reference. 1743-2 and 1729-3 
were derived from crosses conducted by Clyde Denis.
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Table 2 Plasmids Used
Plasmid Relevant Genotype and Marker Source
PYC504 PAB1 [TRP11 Yao et al., 2007
PYC460 PAB1-APC [TRP11 Yao et al., 2007
PYC505 PAB1-ARRM1 [TRP11 Yao et al., 2007
PYC506 PAB1-ARRM2 [TRP11 Yao et al., 2007
PYC507 PAB1-ARRM3 [TRP1] Yao et al., 2007
PYC508 PAB1-ARRM4 [TRP1] Yao et al., 2007
pYC509 PAB1-AC [TRP1] Yao et al., 2007
pYC510 PAB1-AP [TRP11 Yao et al., 2007
pYC513 PAB1-1212PC [TRP11 Yao et al., 2007
PYC525 PABf-Y170V [TRP11 Yao et al., 2007
PYC536 P4B1-F83V [TRP1J Yao et al., 2007
PYC537 R4B1-F83V Y170V [TRP1] Yao et al., 2007
PYC538 R4B7-184 [TRP1] Yao et al., 2007
pYC545 PAB1 -134 [TRP1] Yao et al., 2007
pYC551 P4B1-F366V [TRP1] Yao et al., 2007
PYC552 PAB 1-F263V [TRP17 Yao et al., 2007
pYC562 P4B1-1214PC [TRP1] Yao et al., 2007
PYC570 PAB1-hRRM3 [TRP11 Yao et al., 2007
PYC571 PAB1-1224PC [TRP1] Yao et al., 2007
PYC572 PAB1-1232PC [TRP1J Yao et al., 2007
YEp13 [LEU 2] Hata et al., 1998
YEpMPTO CAF1 [LEU2] Hata et al., 1998
YEpMPT2 CCR4 [LEU21 Hata et al., 1998
PRP1007 GALp-COX17 [LEU2] Olivas and Parker, 2001
Plasmids designatedpYC  were constructed by Yueh-Chin Chiang and used for previous 
analysis in Yao et al., 2007. Other plasmids were obtained from the indicated source. 
All plasmids were transformed into the indicated strain by the LiOAc method (Ito et al., 
1983).
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Results
Effects of Defects in mRNA Degradative Proteins on In Vivo Translation
The determination of the accuracy of the in vivo translation assay that I performed 
was ascertained by comparison of the translation rate with previously determined rates, 
such as that determined for the cdc33-l allele measured by Schwartz and Parker 
(Schwartz and Parker, 1999). All reported translation rates represent the average of two 
or more samples compared to the PAB1 wild type strain and all compared strains are 
isogenic to the PAB1 wild type strain, except for 1729 (contains gstl-1 allele) and 1743 
(containsprtl-63  allele) which are 75% isogenic. Defects in eIF4E are encoded by the 
temperature sensitive allele, cdc33-l, which displayed an average translation rate of 29% 
compared to wild type (Figure 4, Table 3). As mentioned in the introduction, eIF4E, is 
the mRNA cap binding protein involved in cap mediated translation (Jacobson A. and 
Peltz S.W., 1996; von Der Flaar T. et al., 2000; Wells et al., 1998). A decreased 
translation rate was therefore expected in the strain carrying the cdc33-l allele. The 
slightly lower rate of translation in a cdc33-l strain (19%) that was determined 
previously (Schwartz and Parker, 1999) could be due to the differences among the strain 
backgrounds used. My results showed an in vivo translation rate of 45% for the prtl-63  
strain (Figure 4, Table 3). This decreased rate was expected, since at 37°C the prtl-63  
allele causes in vitro and in vivo defects in the translation initiation factor eIF3 (Phan et 
al., 2001; Jivotovskaya et al., 2006; Searfoss et al., 2001). The discrepancy betw een m y 
in vivo translation rate (45%) and the previously reported in vivo translation rate (8%)
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(Schwartz and Parker, 1999) could be caused by two factors. First, the wild type and 
prtl-63  strains are only 75% isogenic, which could result in an error when normalizing 
the prtl-63  strain to wild type. Second, the strain I used and the strain previously used by 
Schwartz and Parker have different backgrounds. What is important is the observation 
that prtl-63  caused a decrease in translation, indicating that the assay is functioning 
properly to show a decreased translation rate when one is expected. The translation 
termination factor eRF3 is encoded by GST1, and the gstl-1 allele confers temperature 
sensitivity (Hosoda et al., 2003). The strain, containing the gstl-1 allele, did not show as 
much decrease in translation rate (62%) as did defects in the translation initiation factors 
(Figure 4, Table 2). Since it is known that translation termination, mRNA deadenylation, 
and translation initiation are related (Hosoda et al., 2003; Kobayashi et al., 2004;
Schwartz and Parker, 1999), it is expected that the decreased rate in a gstl-1 strain was 
observed. Similiarly, with the exception of the caflA deletion, which displayed 35% of 
the translation as of wild type, defects in other mRNA degradation factors all have less 
severe effects on the rate of translation (in the range of 45-78%, Figure 4, Table 3) 
compared to the rates observed for the translation initiation deficient strains (ts eIF4E: 
29%, ts eIF3: 45%). Since some of these were rates comparable to prtl-63, it indicates 
that factors involved in mRNA degradation affect in vivo translation. These observations 
suggest that the assay is functioning properly and should be useful to determine if 
additional mutations have significant major defects in translation. CAF1 displayed the 
most severe defect on in vivo translation and was analyzed further.
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In Vivo Translation Rates of Defective Translation 
Components and mRNA Degradation Components
1 2  i--------------------- - ------------------------------------------------------------------------------
1 -
PAB1 cdc33-1 prt1-63 ccr4A caflA pan3A dhhlA gst1-1 pan2A
Figure 4 -  In vivo translation rates of cdc33-1, prt1-63, PAB1, dcplA, ccr4A, pan3A, dhhlA, and 
gst1-1. Values are averages of mutant relative to wild type PAB1 and SEMs are shown as error 
bars. SEM is the standard error of the mean, and was calculated by dividing the standard 
deviation by the square root of the number of samples. All calculations were done with Microsoft 
Excel software.
Strain Relevant Genotype Mean (rate/WT) SEM Samples
AS319 lpYC504 PAB1 100% 2
AS 188 MpYC504 cdc33-1 29% 4% 12
1743lpYC504 prt1-63 37% 7% 2
AS319-1 alp YC504 ccr4A 55% 5% 7
AS319-C1 lpYC504 caflA 35% 2% 7
DB267lpYC504 pan3A 78% 11% 2
AS319-dhh1 AlpYC504 dhhlA 52% 0% 2
1729-3lpYC504 gst1-1 62% 9% 3
1754-1 -tN/p YC504 pan2A 45% 3% 2
Table 3 Absolute values and number of samples run for Figure 4.
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Translation Rates in PAB1 Domain Deletions
To determine if domain deletions in PAB 1 or PAB1 variants cause major defects 
in translation or if they have only minor effects, I measured the in vivo translation rate of 
PAB1 variants and domain deletions. If the translation rate of a PAB1 domain deletion 
or variant was similar to the translation rate of a defect in translation initiation factors 
eIF3 and eIF4E, then the PAB1 domain or variant probably had a major role in 
translation. However, most individual domain deletions and the PAB1 variants had only 
minor effects on translation (Figures 4 and 5, Tables 3 and 4). Analysis of PAB 1 variants 
and domain deletions displayed translation rates ranging from 70% to 112% of wild type 
(Figure 5, Table 4). Since the translation rate of translation initiation factors, ts eIF4E 
and ts eIF3, was 29% and 45% of wild type, this group of PAB 1 variants and domain 
deletions was not as deficient in translation as with a defect in eIF4E or eIF3, which 
suggested that deletion of individual domains of PAB 1 did not have a major role in 
translation.
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Effect of PAB1 Variants on In Vivo Translation
1.4 
1. 2  -
co
Figure 5 -  Values are averages of the indicated PAB1 variant or domain deletion relative to wild 
type PAB1. Error bars represent SEM. SEM is the standard error of the mean, and was 
calculated by dividing the standard deviation by the square root of the number of samples. All 
calculations were done with Microsoft Excel software.
Strain Relevant Genotype Mean (rate/WT) SEM Samples
AS319 lpYC504 PAB1 100% 4
AS319 lpYC505 PAB1-ARRM1 72% 8% 4
AS319 lpYC536 PAB1-Y83V 90% 12% 3
AS319 lpYC506 PAB1-ARRM2 85% 3% 4
AS319 lpYC525 PAB1-F170V 81% 15% 3
AS319 lpYC545 HPD134DKS 112% 27% 4
AS319 lpYC538 DAL184EKM 96% 5% 3
AS319 lpYC537 PAB1-Y83V, F170V 73% 14% 4
AS319 lpYC507 PAB1-ARRM3 99% 12% 3
AS319 lpYC552 PAB1-F263V 89% 13% 4
AS319 lpYC570 PAB1-hRRM3 74% 10% 3
AS319 lpYC508 PAB1-ARRM4 99% 13% 4
AS319 lpYC551 PAB1-F366V 100% 14% 3
AS319 /pY C 510 PAB1-AP 94% 6% 3
AS319 lpYC509 PAB1-AC 102% 6% 3
AS319/pYC460 PAB1-APC 94% 5% 4
AS319lpYC562 PAB1-1214PC 110% 11% 4
AS319 /pYC571 PAB1-1224PC 70% 14% 3
AS319 lpYC572 PAB1-1232PC 88% 11% 3
AS319 lpYC513 PAB1-1212PC 98% 12% 3
Table 4 Absolute values and number of samples run for Figure 5.
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Translation Rates in the PAB1 RRM1 domain
PAB1-ARRM1 was shown to significantly lower the in vivo translation rate 
compared to wild type (72%). When injected into oocytes, tethered PAB1 RRM1/2 
domains were capable of stimulating translation more than any other domain compared to 
tethered full length PAB1, suggesting the PAB1 RRM1/2 domains have a greater role in 
translation than any other PAB1 domain (Gray et al., 2000). If PAB1 RRM1/2 domains 
are necessary for translation, then deletion of either PAB1 RRM1 domain or PAB1 
RRM2 domain should decrease the in vivo translation rate, which is what I observed for 
the in vivo translation rate in the PAB1-ARRM1 strain. However, in vitro the cap- 
dependent translation and poly(A)-dependent translation for PAB1-ARRM1 displayed a 
significant increase (Otero et al., 1999; Kessler and Sachs, 1998) which is inconsistent 
with my results. In order to determine if the PAB1 RRM1 domain contact to poly(A) 
was necessary for the PAB1 RRM1 requirement for in vivo translation, a point mutation 
in PAB1 RRM1 known to make RNA contact (Y83V) was analyzed. PAB1-Y83V 
resulted in reduced binding to the poly(A) tail as compared to wild-type PAB1 (Yao et 
al., 2007; Deardorff and Sachs, 1997). PAB1-Y83V, however, did not have a significant 
effect on the in vivo translation rate (90%).
Translation Rates in PAB1 RRM2 Variants
PAB1-ARRM2 was shown to significantly lower the in vivo translation rate 
compared to wild type (85%). A PAB1 RRM1 domain deletion and a PAB1 RRM2 
domain deletion resulted in the larger decreases for in vivo translation rates compared to 
other domain deletions (Figure 5, Table 4). This observation suggests that PAB1 RRM1 
and PAB1 RRM2 have a more important role in translation than the other domains, and
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should be able to stimulate translation if tethered to a luciferase reporter. When PAB1 
RRM1/2 tethered to a luciferase reported, translation was stimulated more than any other 
tethered PAB1 domain (Gray et al., 2000). In vitro, PAB 1-ARRIVE was previously 
shown to have a greater than four fold decrease for both cap-dependent translation and 
poly(A) dependent translation compared to wild type (Otero et al., 1999), which is 
inconsistent with my observed in vivo translation rate for PAB1-ARRM2 of 85% of wild 
type. Furthermore, the in vitro translation rate for poly(A)-dependent and cap-dependent 
PAB1-ARRM2 was previously determined to be more than two fold lower than for PAB1- 
ARRM1 (Otero et al., 1999; Kessler and Sachs, 1998), which is inconsistent with my 
determined in vivo translation rates, in which PAB1-ARRM2 resulted in 85% of wild type 
and PAB1-ARRM1 resulted in 72% of wild type (Figure 5, Table 4).
In order to better understand the role of PAB1-RRM2 in translation, three variants 
in the PAB1 RRM2 domain were analyzed. PAB 1-FI70V is defective in binding 
poly(A) (Deardorff and Sachs, 1997). PAB 1-184 carrying the mutations DAL to EKM 
fails to bind eIF4G in vitro (Otero et al., 1999) although in vivo it is still able to make 
contact to eIF4G, albeit to a lesser extent (Y.C. Chiang, personal communication) and 
PAB1-134 has the mutations HPD to DKS. The measured in vivo translation rate of a 
point mutation in PAB1 RRM2 important for RNA binding (F170V) (Yao et al., 2007; 
Deardorff and Sachs, 1997) was 81%. However, the SEM of 15% indicates that 
additional samples are needed to determine if the decreased rate is significant. This 
preliminary observation suggests that the PAB1 RRM2 poly(A) contact is important for 
translation. In vitro PAB 1-184 showed an increase in cap-dependent translation 
compared to PAB1-ARRM2 and was as defective in poly(A)-dependent translation as
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PAB1-ARRM2, indicating that PAB 1-184 is defective in poly(A) dependent translation 
and capable of stimulating cap-dependent translation (Otero et al., 1999). The PAB 1-184 
in vivo translation rate was determined to be 96%, which is in agreement with the in vitro 
translation rate for cap-dependent translation but in disagreement with the in vitro 
translation rate for poly(A)-dependent translation. The in vitro translation rate for PAB1- 
134 was similar to PAB1-ARRM2 for cap-dependent translation but poly(A)-dependent 
translation was increased more than four fold compared to PAB1-ARRM2 (Otero et al.,
1999). The in vivo translation rate for PAB 1-134 was measured at 112% which is in 
agreement with the in vitro poly(A)-dependent translation rate, but disagrees with its 
effect on the in vitro cap-dependent translation rate (Otero et al., 1999).
Translation Rates in PAB1-RRM3
Deletion of the complete region of PAB1-RRM3 had no effect on in vivo 
translation (99%) compared to wild type. Tethering of PAB 1 RRM3/4 to a luciferase 
reporter decreased translation slightly (93%) compared with tethered full length PAB1 
(Gray et al., 2000). This indicates that PAB1 RRM3/4 does not have a large role in 
translation. If the PAB1 RRM3/4 domains do not play a role in translation, then deletion 
of PAB 1 RRM3 or PAB1 RRM4 should show no significant change in the in vivo 
translation rate, which is what is observed for both domains (see next section for PAB1- 
ARRM4 data). In vitro, the deletion increased poly(A)-dependent and cap-dependent 
translation (Otero et al., 1999; Kessler and Sachs, 1998). A point mutation (F263V) in 
the PAB1 RRM3 domain important for binding RNA (Yao et al., 2007; Deardorff and 
Sachs, 1997) had no significant effect on in vivo translation (89%), further suggesting the 
PAB1 RRM3 domain is unimportant for translation. However, substitution of the PAB1
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RRM3 domain with the PAB1 RRM2 domain (PAB1-1224PC) gave 70% of the wild- 
type in vivo translation rate. This was the largest decrease for in vivo translation rate 
observed in the PAB1 domain deletions and variants (Figure 5, Table 4). In contrast, 
substitution of the PAB1 RRM3 domain with the PAB1 RRM1 domain (PAB1-1214PC) 
showed an in vivo translation rate of 110%. The PABl-hRRM3 variant did show a 
decreased in vivo translation rate of 74%. However, as no other human PAB1 domain 
substitutions were available at the time, it was not possible to compare this result to other 
human PAB 1 domain substitutions.
Translation Rates in PAB1-RRM4. PAB1-P, PAB1-C Deletions
Analysis of the translation rates for PAB1-ARRM4 (99%), PAB1-AP (94%),
PAB 1-AC (102%), and PAB1-APC (94%) showed no significant differences compared to 
the wild-type PAB1 strain (Figure 5, Table 4). Additionally, mutation of a PAB1 RRM4 
residue (Y366V), important for RNA contact (Yao et al., 2007; Deardorff and Sachs,
1997) further indicates that changes in the PAB1 RRM4 domain do not affect in vivo 
translation. Previous in vitro translation rates indicate that deletion of the PAB1 RRM4 
domain decreased cap-dependent and poly(A) dependent translation (Otero et al., 1999; 
Kessler and Sachs, 1998), which is inconsistent with my in vivo translation rate. Previous 
analysis of the C terminus of PAB 1 was done with a truncation of both PAB1 P/C 
domains which showed cap-dependent translation to be higher than wild type (Otero et 
al., 1999) and lower than wild type for poly(A)-dependent translation (Kessler and Sachs,
1998). The in vivo translation rates I determined for the PAB1-AP, PAB1-AC, and PABJ- 
APC strains were consistent with the in vitro PAB1-APC cap-dependent rate but 
inconsistent with the poly(A)-dependent rate. In vivo translation rates measured with
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injected oocytes showed that tethered PAB1 PC domains were less capable of stimulating 
translation compared to the full length PAB1, indicating the PAB1 P and PAB1 C 
domains have no role in translation or act to suppress translation (Gray et al., 2000). If 
PAB1 P and PAB1 C domains act to suppress translation then deletion of the domains 
should increase the rate of translation, whereas if PAB1 P and PAB1 C domains have no 
role in translation then deletion of either domain should not affect the in vivo translation 
rate. The latter hypothesis agrees with the in vivo translation rates that I observed for 
PAB1-AP, PAB1-AC, and PAB1-APC.
Translation Rates in ts eIF3 with PAB1 Variants
In vivo translation rates were measured in a strain with the prtl-63  allele and 
PAB1 domain deletions. The following rates of translation were observed: PAB1- 
ARRM1 (56%), PAB1-ARRM2 (44%), PAB1-ARRM3 (39%), PAB1-ARRM4 (44%), 
PAB1-AP (50%), and PAB1-AC (42%) (Figure 6, Table 5). Compared to the prtl-63  
allele alone (45%) the translation rates for the PAB1 domain deletions and almost all 
PAB1 variants in the presence of prtl-63 displayed no significant difference (Figure 6, 
Table 5). The only significant difference was for PABl-f34 (31%) that was much lower 
than prtl-63  alone (45%). More determinations would be needed to verify that 
observation, but it does suggest that the lesion in PAB1-134 functionally interacts with 
eIF3 to decrease translation.
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Figure 6 -  Average values for prt1-63 with PAB1 variants and domain deletions. Values are 
relative to the wild-type parent strain. Error bars represent SEM. SEM is the standard error of 
the mean, and was calculated by dividing the standard deviation by the square root of the number 
of samples. All calculations were done with Microsoft Excel software.
Strain Relevant Genotype Mean (rate/WT) SEM Samples
AS319 lpYC504 PAB1 100% 2
1743lpYC504 prt1-63 PAB1 37% 7% 2
1743!pYC505 prt1-63 PAB1-ARRM1 56% 6% 2
1743lpYC536 prt1-63 PAB1-Y83V 44% 4% 2
1743/pYC506 prt1-63 PAB1-ARRM2 38% 5% 2
1743/pYC525 prt1-63 PAB1-F170V 30% 6% 2
1743lpYC537 prt1-63 PAB1-Y83V,F170V 25% 5% 2
1743/pYC545 prt1-63 HPD134DKS 31% 4% 2
1743lpYC538 prt1-63 DAL184EKM 38% 8% 2
1743lpYC507 prt1-63 PAB1-ARRM3 39% 3% 2
1743lpYC508 prt1-63 PAB1-ARRM4 44% 5% 2
1743/p YC510 prt1-63 PAB1-AP 50% 3% 2
1743/pYC509 prt1-63 PAB1-AC 42% 4% 2
1743/pYC513 prt1-63  P A B 1 -1 2 1 2 P C 30% 3% 2
Table 5 Absolute values and number of samples run for Figure 6.
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Translation Rates in ts eIF4E with PAB1 Variants
Translation rates measured in the cdc33-l background varied from day to day so 
in order to confirm a significant difference, the rates obtained for a sample on a specific 
day or set of days had to be compared against the observed cdc33-l rate for the same 
specific day or set of days as the sample being analyzed. The average in vivo translation 
rate obtained for the cdc33-l allele alone (29%, Figure 7, Table 6) was taken from 12 
samples. Since this average is taken from a large sample size it was considered to be 
representative of the affect of cdc33-lon translation. The average in vivo translation rates 
for the remaining PAB1 variants and deletions in the cdc33-l background were taken 
from two to seven samples. If in vivo translation rates for a particular variant were 
measured outside the mean, those values were compared with rates for the wild type 
PAB1 in the cdc33-l background on the same day. PAB1-134 (15%, Figure 7, Table 6) 
in a cdc33-l background showed an average rate significantly lower than the mean 
translation rate of the cdc33-l allele alone (29%, Figure 7, Table 6). However, as the 
translation rates varied from day to day, cdc33-l PAB1-134 rates were measured at 14% 
and 17% (data not shown) and on the same days the translation rates for the cdc33-l 
allele alone were measured at 12% and 14% (data not shown), indicating that the PAB1- 
134 protein does not affect translation significantly in a cdc33-l strain. cdc33-l PAB1- 
ARRM4 showed an in vivo translation rate of 15% (Figure 7, Table 6) with SEM of 4%, 
which is significantly lower than cdc33-l PAB1. However, on the same day that cdc33-l 
PAB1-ARRM4 was analyzed, cdc33-l PAB1 showed in vivo translation rates of 16%, 
19%, 20%, and 21%, averaged to 19% with SEM of 1% (data not shown) which indicates
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that cdc33-l PAB1-ARRM4 is not significantly different from the mean. In an effort to 
better understand the interaction between eIF4E and the PAB1 RRM2, domain we then 
analyzed the in vivo translation rate of the PAB1-184 protein (14%, Figure 7, Table 6), 
which is significantly lower than the cdc33-l allele alone (29%, Figure 7, Table 6). In 
contrast, when compared against another mutation in the RRM2 domain of PAB1 
(FI70V, Table 2), which results in decreased mRNA contact, showed no difference in 
translation rate (22%, Figure 7, Table 6) compared to the cdc33-l allele alone (29%, 
Figure 7, Table 6). The remaining PAB1 variants do not show any significant difference 
compared to the cdc33-l allele (Figure 7, Table 6). These observations indicate that 
PAB1-184 caused a reduced in vivo translation rate when combined with a defect in the 
cap binding protein, eIF4E. It has been shown that, in vitro, PAB1-184 is incapable of 
binding eIF4G (Otero et al., 1999) and since eIF4G is responsible for contacting 
additional translation initiation complexes (Neff and Sachs, 1999; Dominguez et a l,
1999) it is logical that abrogating contact between both the cap (eIF4E) and poly(A) tail 
(PAB1-184) to eIF4G would cause a greater impairment to translation.
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Figure 7 -  Average values for cdc33-1 with PAB1 mutations. Values are relative to the wild-type 
parent strain.
Strain Relevant Genotype Mean (rate/WT) SEM Samples
AS319 lpYC504 PAB1 100% 2
AS 188 MpYC504 cdc33-1 PAB1 29% 4% 12
AS 1881 lpYC505 cdc33-1 PAB1-ARRM1 22% 2% 2
AS 188 MpYC525 cdc33-1 PAB1-F170V 22% 5% 5
AS 1881 lpYC545 cdc33-1 HPD134DKS 15% 1% 2*
AS 1881/0/0538 cdc33-1 DAL184EKM 14% 3% 5
AS 188 MpYC507 cdc33-1 PAB1-ARRM3 23% 6% 2
AS 188 MpYC508 cdc33-1 PAB1-ARRM4 15% 4% 2*
AS1881/p YC510 cdc33-1 PAB1-AP 28% 7% 2
ASt88MpYC509 cdc33-1 PAB1-AC 22% 1% 2
Table 6 -  Average values for cdc33-1 with PAB1 mutations and domain deletions. The strains 
indicated by * show a significant decrease in the mean, however comparison with the cdc33- 
1/PAB1 rate obtained on the same day was not significantly different.
43
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Analysis of CCR4 and CAF1 Effects on Translation
CCR4 and CAF1 are two components of the CCR4-NOT deadenylase complex 
shown to play a role in deadenylation. When deleted, cafl and ccr4 showed in vivo 
deadenylation defects (Tucker et al., 2001). Defects caused by a cafl deletion can be 
rescued by over-expression of CCR4. However, defects associated with a ccr4 deletion 
cannot be rescued by over-expression of CAF1 (Tucker et al., 2001; Chen et al., 2002; 
Tucker et al., 2001). Moreover, mutation of predicted key catalytic active sites in CAF1 
did not affect in vivo deadenylase activity (Viswanathan et al., 2004), whereas point 
mutations in the predicted catalytic active sites in CCR4 does cause a defect in 
deadenylation (Chen et al., 2002). Genetic evidence suggests that CAF1 plays a role in 
translation, whereas CCR4 does not (Ohn et al., 2007; Coller and Parker, 2005; Maillet 
and Collart, 2002). These observations suggest that CAF1 and CCR4 have different roles 
in deadenylation and translation.
In order to determine if in fact CCR4 and CAF1 have functions in translation we 
asked whether or not cafl A and ccr4A strains show a decreased translation rate. A 
decrease in translation rate was observed for both CCR4 and CAF1, 55% for ccr4A and 
35% for cafl A. This indicates that both CCR4 and CAF1 have roles in translation, but 
CAF1 is more critical for translation than CCR4. Since it has been shown that a cafl 
deletion is lethal when combined with PAB1-ARRM2 and a ccr4 deletion is viable when 
combined with PAB1-ARRM2, we then asked how the PAB1 RRM2 variants affect in 
vivo translation rates when combined with cafl A and ccr4A. When expressed in a cafl A 
strain, PAB1-184 raised the translation rate to 50%. PAB1-134, in contrast, displayed 
little effect when combined with cafl A and resulted in a rate of 30%. In a ccr4A
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background both PAB1-184 and PAB1-134 decreased the in vivo translation rate to 38% 
and 46%, respectively (Figure 8, Table 7). These results suggest that the PAB1-184 
mutations rescue the defect in translation caused by cafl A.
The synthetic lethality observed when combining a cafl A with the PAB1 domain 
deletion PAB1-ARRM2 suggests that CAF1 has a similar translational role as eIF4E 
because the cdc33-l allele also displayed a synthetic lethality with PAB1-ARRM2 
(unpublished results). Because of this observation we asked how the cdc33-l allele 
affects the translation rate in a cafl A or cc,r4A background. In the cdc33-l cafl A strain 
we saw a much lower in vivo rate of translation (13%) than cdc33-l ccr4A (24%). 
Compared to the cdc33-l allele alone (29%), cdc33-l cafl A has a more significant effect 
on in vivo translation than cdc33-l ccr4A, implying that CAF1 and CCR4 have different 
roles in translation. Previous deadenylation data regarding CAF1 and CCR4 imply the 
two proteins have a role in deadenylation, albeit apparently, separate roles (Ohn, et al.
2007). My data suggests that CAF1 and CCR4 do in fact have roles in translation, but 
those roles are separate as well as the roles in deadenylation.
Since over-expression of CAF1 rescues the lethality of the cdc33-l allele (Ohn, et 
al. 2007), and since the cdc33-l allele confers a defect in the translation initiation factor 
eIF4E it is reasonable to imagine that CAF1 rescues the cdc33-l lethality by increasing 
the rate in translation when over-expressed. If, in fact, CAF1 has a role in translation 
similar to eIF4E, then we would expect that over-expressed CAF1 would increase the rate 
of translation in a strain with the cdc33-l allele. CAF1 and CCR4 were over-expressed 
from a YEpl3 plasmid which was introduced into a strain carrying the cdc33-l allele.
The in vivo translation rate of cdc33-l/YEpl3-CAFl was measured and normalized to the
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wild type parent strain with a YEpl3 plasmid, cdc33-HYEpl3. In order to determine if 
CCR4 has a different role in translation than CAF1, the in vivo translation rate of over­
expressed CCR4 was also measures in a strain carrying the cdc33-l allele. The cdc33-l 
allele alone, cdc33-l/YEpl3 showed an in vivo translation rate of 38% ±7% (Figure 8, 
Table 7), cdc33-l/YEpl3-CCR4 (31%±7%, Figure 8, Table 7) and cdc33-l/YEp!3-CAFl 
(49%±6%, Figure 8, Table 7) did not show a significant difference compared to the 
cdc33-l allele alone, due to overlapping SEM values. This suggests that over-expressed 
CAF1 does not rescue a lesion in eIF4E by increasing in vivo translation rates. 
Furthermore, this observation indicates that CCR4 does not have a significant 
translational effect when combined with a defect in eIF4E. Although, these results do not 
show that over-expressed CCR4 and CAF1 significantly increase or decrease in the rate 
of translation from the translation rate of the cdc33-l allele alone, the in vivo translation 
rates for cdc33-l/YEpl3-CCR4 and cdc33-l/YEpl3-CAFl are significantly different from 
one another. This suggests that over-expressed CAF1 and over-expressed CCR4 affect 
the translation rate differently when combined with a defect in eIF4E, supporting the 
hypothesis that CAF1 and CCR4 do in fact have different roles in translation.
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Effect of CAF1 and CCR4 on PAB Variants and ts 










Figure 8 -  Values are the average of the rate relative to the wild-type parent strain. Error bars 
represent SEM.
Strain Relevant Genotype Mean (rate/WT) SEM Samples
AS319 lpYC504 PAB1 100% 4
AS319-1 a/p YC504 ccr4A PAB1 55% 5% 7
AS319-1a lpYC545 ccr4A HPD134DKS 46% 14% 4
AS319-1 a/pYC538 ccr4A DAL184EKM 38% 7% 3
AS1881-1 a/ pYC504 cdc33-1 Acer4 24% 4% 3
AS319-c1/p YC504 caflA PAB1 35% 2% 7
AS319-C1 ipYC545 caflA HPD134DKS 30% 8% 3
AS319-c1 Ip YC538 caflA DAL184EKM 50% 6% 3
AS 1881 -c1 JpYC504 cdc33-1 Acafl 13% 4% 3
AS1881/YEpf3 cdc33-1 YEp13 38% 7% 4
AS1881//WPT2 cdc33-1 YEp-CCR4 31% 7% 3
AS1881//WPTO cdc33-1 YEp-CAF1 49% 6% 4
T ab le  7 A b so lu te  v a lu e s  a n d  n u m b e r  of s a m p le s  run for F igure  8.
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Discussion
Previous studies analyzing the role of PAB1 in translation have been limited to in 
vitro studies (Otero et al., 1999; Kessler and Sachs, 1998) and the ability of PAB1 
domains to stimulate translation (Gray et al., 2000). The in vitro studies have been useful 
for determining a link between the PAB1 RRM2 domain, eIF4G, and translation but the 
results do not agree with the observed in vivo translation rates that I have observed. It is 
known that PAB1 is involved in various aspects of mRNA transport (Brune C, et al 
2005), mRNA biogenesis (Dunn EF, et al 2005), and mRNA deadenylation (Yao, et al 
2007, Caponigro G and Parker R 1995), so differences in the observed in vivo translation 
rates and in vitro translation rates could be due to pleiotropic effects associated with a 
PAB1 domain deletion or variant. Analysis of PAB1 domains able to simulate translation 
in Xenopus oocytes is difficult to compare side by side with the analysis of translation 
rates in the domain deletions because different domains are examined. Specifically, the 
domains deleted were much smaller than the domains used for the analysis of translation 
stimulation. Additionally, the ability of a PAB1 domain capable of translation 
stimulation determines if the domain is sufficient for translation, the deletion analysis 
determines if  the domain is necessary for translation. Despite these problems, when 
analyzing the PAB1 domains capable of translation stimulation, PAB1 RRM1/2,1 am 
able to conclude that the PAB1 RRM1 and PAB1 RRM2 domains are both necessary and 
sufficient for translation. The domains of PAB1 unable to stimulate translation compared 
to full length PAB1 were PAB1 RRM3/4 and PAB1 P/C. This indicates that the only
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domains sufficient for translation are PAB1 RRM1/2. Additionally, when analyzing a 
deletion of the domains incapable of translation stimulation, I observed that in vivo 
translation rates were unaffected, indicating that the PAB1 RRM3, PAB1 RRM4, PAB1 
P, and PAB1 C domains are not necessary for translation.
One purpose of this study was to determine the role of PAB1 in translation.
Based on these findings, deletions in PAB1 do not have a major role in translation. The 
domain deletion with the largest decrease in translation rate was PAB1-ARRM1 (72%, 
Figure 5, Table 4). Compared against defects in known translation factors, ts eIF3 (45%, 
Figure 4, Table 3) and ts eIF4E (29%, Figure 4, Table 3) the PAB1 domain deletion with 
the largest decrease in translation rate is still much higher than defects in known 
translation factors. The rates for PAB1 domain deletions and variants (70-112%, Figure 
5, Table 4) are more similar to translation rates observed in strains with defects in mRNA 
degradation, except for cafl A. (45-78%, Figure 4, Table 3).
Based on the observation that PAB1 does not have a large role in translation, 
combination of PAB1 domain deletions and variants with lesions in eIF3 and eIF4E 
should not affect in vivo translation rates. The only PAB1 variant that significantly 
lowered the in vivo translation rate in the ts eIF4E strain was PAB1-184 (14%, Figure 7, 
Table 6) compared to the ts eIF4E strain alone (29%, Figure 7, Table 6). Since PAB1- 
184 abrogates eIF4G contact (Otero et al., 1999) and eIF4G is responsible for contacting 
additional translation factors (Neff and Sachs, 1999; Dominguez et al., 1999), then 
combining a defect in eIF4E with PAB1-184 should decrease translation rates. In order 
to show more definitively that the contact between eIF4G and PAB1 is causing the 
decreased in vivo translation rate, another PAB1 variant known to decrease eIF4G
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binding could be analyzed. Such a variant is PAB1-180, which carries the mutation KE 
to ER and diminishes in vitro cap-dependent, poly(A) dependent translation, and binding 
to eIF4G (Otero, et al., 1999). The PAB1 variant PAB1-134 decreased the in vivo 
translation rate in the ts eIF3 strain to 31% (Figure 6, Table 5), which is significantly 
lower than the ts eIF3 strain alone (45%, Figure 6, Table 5). Flow PAB1-134 interacts 
with the translation factor, eIF3, is unclear, but the observed results indicate that PAB1- 
134 acts on translation through a different mechanism than PAB1-184.
Another reason for this study was to determine if CAF1 and CCR4 have roles in 
translation and if those roles are similar. Since the role in deadenylation of CAF1 and 
CCR4 appears to be different, it would follow that the role in translation would be 
different as well. Based on these results it does appear that both CAF1 and CCR4 have 
roles in translation (Figure 8, Table 7), with the role of CAF1 being more critical than 
CCR4. Combining defects in eIF4E (cdc33-l) with a lesion in cafl or ccr4 showed that a 
cafl deletion decreased translation rates (15%, Figure 8, Table 7) more than a ccr4 
deletion (24%, Figure 8, Table 7). These last observations support the hypothesis that 
CAF1 has a greater role in translation than CCR4, and that the two proteins act through 
different mechanisms. Furthermore, a PAB1-184 variant increased the in vivo translation 
rate in a cafl A strain to 50% of wild type (Figure 8, Table 7), whereas a ccr4A strain 
PAB1-184 lowered the rate to 38% of wild type (Figure 8, Table 7). This last 
observation indicates that deleting ccr4 caused a similar decrease in translation as did a 
cdc33-l allele, since the double mutant, cdc33-l PAB1-184 (14%) showed a lower 
translation rate compared to the cdc33-l allele alone (29%, Figure 7, Table 6). How
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CCR4 and CAF1 function in translation is unclear at this time. What is clear is that both 
CCR4 and CAF1 do have a role in translation and that role is different from one another.
Analysis of additional strains could provide the necessary insight to make a more 
conclusive summary of this work. As mentioned in the discussion PAB1-180 showed 
reduced in vitro contact between eIF4G and PAB1. If PAB1-180 shows a lowered in 
vivo translation rate, similar to PAB1-184, when combined with a cdc33-l allele then the 
hypothesis that decreasing contact between PAB1 and eIF4G is the reason for the 
decreased cdc33-l PAB1-184 translation rate would be supported. Additionally, 
combining PAB1-180 with PAB1-184 could be analyzed and would also support the 
stated hypothesis if a decreased translation rate is observed. Correspondingly, combining 
the PAB1-180 and PAB1-180, 184 variants with lesions in ccr4 and cafl would provide 
additional information about how CCR4 and CAF1 function in translation.
The PAB1 variants, PAB1-134 and PAB1-184, represent substitutions of yeast 
residues with the homologous human residues in the RRM2 domain. These variants have 
provided some additional insight into how PAB1 functions in translation and substitution 
of additional domains would provide additional information into how PAB1 functions in 
translation. Analysis of a human substitution of PAB1 RRM3 has been done (Figure 5, 
Table 4), but since no other domain substitutions were available for analysis at the time, 
proper comparisons were not available to determine the significance of the decreased in 
vivo translation rate for PABl-hRRM3. If the remaining domains were to be analyzed, 
we could obtain more information about how the PAB1 domains are involved in 
translation. For example, the PAB1-ARRM3 domain deletion did not show a large 
decrease in translation, but the PABl-hRRM3 variant did show a larger decrease in
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translation. If PABl-hRRMl shows a large decrease in translation, then the PAB1- 
hRRM3 decrease is probably a general effect due to changing the yeast domain with the 
human domain. If PABl-hRRMl does not show a large decrease for the in vivo 
translation rate, then we would hypothesize that the PAB1 RRM3 domain does in fact 
play a role in translation, and the next step would be to make smaller substitutions in 
RRM3. Obviously, additional work is needed to make more definitive conclusions, and 
the work reported thus far has provided some observations that could be investigated 
further.
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CHAPTER II
C0X17 DEADENYLATION RATES IN PAB1 VARIANTS
Introduction
Proper and appropriate gene expression is essential for all biological organisms. 
Regulation of gene expression is necessary for many biological cues, such as: 
embryological development, metabolic changes, cell cycle stages, and viral infection. 
Gene expression can be controlled at many levels, ranging from transcriptional start 
signals, mRNA degradation, and post-translational modifications. Because the longer a 
mRNA transcript persists, the more protein can be translated from the transcript, and 
conversely, the shorter a mRNA half-life is the less protein can be produced from the 
corresponding mRNA transcript, one area of particular interest is gene regulation at the 
level of mRNA degradation.
In Saccharomyces cerevisiae, a mature mRNA consists of a 3’ poly(A) tail, 
approximately, 90-110 adenines in length, a m7Gppp cap at the 5’ ribonucleotide, and all 
introns spliced from the mRNA body. Degradation of the mRNA begins with 
deadenylation of the poly(A) tail by the PAN2/3 complex, which exonucleolytically 
digests approximately 20 adenines (A ’s). The CC R4-N O T com plex then  digests the 
poly(A) tail to a length of 8-12 adenines (Tucker et al., 2001). At this length the poly(A) 
binding protein (PAB1) cannot efficiently bind the poly(A) tail, thus signaling decapping 
(Coller et al., 1998; Sachs et al., 1987). The 5’ m7Gppp cap structure is cleaved through
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numerous proteins, such as DCP1/2, DHH1, EDC1, EDC2, LSM1-7, and PAT1 
(Dunckley and Parker, 1999; Bouveret et al., 2000; Schwartz et al., 2003; Bonnerot et al., 
2000). Decapping allows for degradation of the mRNA body 5’ to 3’ by XRN1 
(Muhlrad et al., 1994). Additionally, degradation by the exosome can occur in the 3’ to 
5’ direction (Anderson and Parker, 1998; Mitchell et al., 1997).
As mentioned in the general introduction, several observations indicate that 
deadenylation is the first and rate limiting step of mRNA degradation. Briefly, elements 
in the UTR of mRNA that promote rapid degradation also promote accelerated 
deadenylation rates (Decker and Parker, 1993; LaGrandeur and Parker, 1999; Caponigro 
and Parker, 1996), and deadenylation rates of stable transcripts are much slower than 
transcripts that degrade rapidly (Decker and Parker, 1993; LaGrandeur and Parker, 1999). 
Since deadenylation is the first and rate limiting step of mRNA degradation, 
understanding how deadenylation occurs is crucial to understanding how differential 
mRNA degradation occurs.
The PUF family of proteins, as mentioned in the general introduction, is a group 
of proteins responsible for translational repression and accelerating deadenylation of the 
target transcript. It has been shown that PUF3 accelerates deadenylation of COX17 
(Olivas and Parker, 2000). One approach to determining how deadenylation is 
accelerated or decelerated is to investigate the mechanism that PUF3 accelerates 
deadenylation.
Two models can explain how PUF3 accelerates mRNA deadenylation. The first 
is a simple recruitment model. It has been shown that the PUF consensus sequence in the 
5’ or 3’ UTR is capable of shortening the half life of an mRNA (Olivas and Parker, 2000;
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Graber, 2003). These flanking sequences bind proteins, such as PUF proteins, which in 
turn bind mRNA degradation proteins, such as the CCR4-NOT complex (Figure 2A), 
thus bringing the target mRNA into closer proximity to the degradation proteins. It has 
been shown that PUF5 is capable of contacting CAF1 (Goldstrohm et al., 2006), which 
contacts the major cytoplasmic deadenylase, CCR4. This observation provides support 
for the recruitment model. The second model involves rearrangement of the mRNP 
structure. The mRNP complex is composed of many proteins, but the core complex 
consists of a mature mRNA, the cap binding protein, eIF4E, the poly(A) binding protein, 
PAB1, and eIF4G, a bridging protein between eIF4E and PAB1. Through contact with 
eIF4E, eIF4G, or PAB1 the PUF proteins could perturb the mRNP structure, allowing 
mRNA degradation proteins access to the mRNA transcript (Figure 2B). Support for the 
mRNP disruption model is shown through PUF3 and PUF5 co-immunoprecipitation of 
eIF4E (Y. Chiang, personal communication). This suggests that PUF3 and PUF5 contact 
the mRNP complex through eIF4E. The two models are not mutually exclusive, 
however. It is possible PUF proteins could simultaneously recruit mRNA degradation 
components and destabilize the mRNP complex (Figure 2C).
The role of eIF4E in deadenylation is not completely understood, but several 
observations suggest it has an inhibitory role and interacts with PAB1. A cdc33-I allele, 
encoding a temperature sensitive eIF4E protein, defective in cap binding (Altmann and 
Trachsel, 1989), displayed an accelerated deadenylation rate for GAL1 (T. Ohn, personal 
communication) and PGK1 (Schwartz and Parker, 1999), but not MFA2 (Schwartz and 
Parker, 1999), suggesting that eIF4E has an inhibitory effect on deadenylation of 
transcripts with an average to long half-life. Furthermore, deletion of PAB1 RRM1 and
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PAB1 P domains, the two domains of PAB1 that showed the greatest defects in 
deadenylation and are responsible for circularization of PAB1 (Yao et al., 2007), 
displayed accelerated deadenylation of GAL1 with a defect in eIF4E (T. Ohn, personal 
communication). Formation of the circular PAB1 promotes deadenylation, so this last 
observation suggests that eIF4E has a role in the circularization of PAB1. PAB1 is in 
close proximity to eIF4E and we have shown that PAB1 co-immunoprecipitates eIF4E 
(Y. Chiang, personal communication). One hypothesis is that PUF3 interacts with eIF4E 
to disrupt PAB1 poly(A) binding by promoting the circularization of PAB1. By 
understanding the role of PAB 1 in deadenylation we hope to understand how the mRNP 
structure is involved in deadenylation.
In order to determine the role of PAB 1 in the differential degradation of a mRNA 
transcript, deadenylation rates have been determined of an unstable mRNA and a mRNA 
with an average half-life. Two mRNA suitable for comparison in the PAB1 variants are, 
MFA2 which displayed a half-life of 3.5 minutes (Schwartz and Parker, 1999) and is 
relatively fast, and GAL1 which has a mRNA half-life of 10 minutes (Cui and Denis, 
2003) and is a rate more similar to the average mRNA half-life. If one PAB1 variant had 
an effect on MFA2 that did not occur in GAL1, then the conclusion would be that the 
particular PAB1 domain has a role in differential deadenylation. However, all PAB1 
variants had the same effect on GAL1 and MFA2 (Yao et al., 2007), indicating that PAB1 
does have a role in deadenylation, but that role may be a general role for transcripts with 
an average and a fast deadenylation rate. If, in fact, PAB1 does have a general role in 
mRNA deadenylation, then the deadenylation rate for the PAB 1 variants should be 
similar for all transcripts. COX17 encodes an mRNA with a relatively fast half-life
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(Olivas and Parker, 2000), and a fast deadenylation rate (Olivas and Parker, 2000), so it 
would be expected that COXl7 would behave similar to MFA2. Since, it is known that 
the mRNA binding protein, PUF3, accelerates deadenylation of COX17 mRNA (Olivas 
and Parker, 2000), analysis of the deadenylation rate of COXl 7 in each of the PAB1 
variants would provide insight into the mechanism whereby PUF3 accelerates 
deadenylation.
In this work I have analyzed the deadenylation rate of COXl 7 in PAB1 variants 
containing a deletion for each of the domains, and have shown that PAB1-ARRM1 
blocked deadenylation of COXl 7 and PAB1-A.P displayed a more similar deadenylation 
pattern to wild-type. Previously, PAB1-ARRM1 and PABl-kP  displayed a slower 
deadenylation rate for both MFA2 and GALI (Yao, et al., 2007). The observation that 
deadenylation rates for COXl 7 are different compared to MFA2 and GALI in the PAB1 
variants indicates that PAB1 has a role in deadenylation that is different for a mRNA that 
is dependent on PUF3 for proper deadenylation.
Materials and Methods 
Strains and Plasmids Used
Strains and plasmids are listed in Tables 1 and 2. 
Oligonucleotides Used
Table 8 Sequence of Probes Used for Northern Analysis
Probe Name Sequence
COX17/dn 5' GCCATAACCCTTCATGCACTC
COX17/3' end 5' GGTTGTCGGCAGACTGTCAG
SCR1 probe250 5' ATCCCGGCCGCCTCCATCAC
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Growth Conditions and Pulse-Chase
All strains were grown in 0.67% yeast nitrogen base without amino acids, and 
amino acids as required (synthetic medium) containing 2% raffinose until exponential 
growth phase was reached. Leucine was omitted from synthetic medium (leu- medium) 
to ensure the presence of pRP1007. Cells were then resuspended in five mL of leu- 
medium containing 2% raffinose. One mL of 25% galactose was added to induce 
expression of the GAL10 promoter. Twenty minutes after induction, one mL of 50% 
glucose was added, and one mL aliquots were removed and quick frozen in dry ice at the 
designated time points.
RNA Analysis
RNA isolation. The hot phenol method was used to isolate total RNA. 500 pL of 
TES (10 mM Tris pH 7.5, 10 mM EDTA, 0.5% SDS) and 500 pL of phenol were added 
to frozen cells. Following a 65°C incubation with frequent vortexing, the mixture was 
spun, and the aqueous layer removed. The aqueous layer was then cleared of protein and 
lipids with a phenol wash, followed by a chloroform wash. RNA was then precipitated 
with 100% ethanol and 1/10 volume 3M NaOAc pH 5.3. The pellet was washed in 70% 
ethanol, dried and resuspended in 50 pL of DEPC treated water.
RnaseH digestion and analysis. 12-30 pg of RNA was incubated with the 
COX17/dn probe at 75°C for ten minutes, and then one hour at 30 °C. An additional 
sample was also hybridized to a DNA oligo-thymidine (dT), in addition to the COX17/dn 
probe. The dT hybridizes to the poly(A) and RNaseH digestion removes the poly(A) tail 
and also cleaves at the COX17/dn site. The dT sample allows for visualization of the 
fully deadenylated fragment following Northern analysis. One U RNaseH was added
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with RNaseH buffer (40mM Tris pH 7.5, 20mM MgCh, lOOmM NaCl, 2mM DTT, 60 
pg/mL BSA) and allowed to digest at 30 °C for one hour. Two hundred and eighty pL 
stop buffer was added (0.04 mg/mL tRNA, 300mM NaOAc, 20mM EDTA), and the 
digested RNA was cleared of protein with phenohchloroform (1:1), and chloroform. The 
RNA was precipitated with 100% ethanol and washed with 70% ethanol. RNA was then 
separated on a 6% urea polyacrylamide gel, transferred to a nitrocellulose membrane and 
probed using a [32P]-labeled COXl7/3’ end probe. Phophor imaging screen - K was used 
to detect radio-labeled COXl 7 mRNA, the screens were scanned using the Bio-Rad 
Molecular Imager - FX, and Quantity One software was used to print and manipulate the 
images. Following detection of COXl 7, membranes were re-probed for small 
cytoplasmic RNA 1 (SCR1). SCR1 is an abundant RNA with a very long half-life and no 
poly(A) tail, making it a very useful loading control.
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Results
COXl 7 Behaves as Expected in a PAB1 Wild Type Strain and in a PAB1 Wild Type 
Strain Containing a PUF3 Deletion
Since it is known that COXl 7 mRNA requires PUF3 for deadenylation of the 
poly(A) tail (Olivas and Parker, 2000; Jackson et al., 2004; Houshmandi and Olivas, 
2005), COXl 7 is a suitable mRNA for determining if PAB 1 is involved in PUF3- 
mediated deadenylation. COXl 7 expression was driven by a GAL 10 promoter allowing 
for synthesis of COXl 7 mRNA upon addition of galactose (pulse) to exponentially 
growing cells. Deadenylation of the COXl 7 mRNA followed after transcription of 
COXl 7 mRNA was shut-off with glucose (chase). Deadenylation of COXl 7 was 
analyzed in PAB1 domain deletions with wild-type PUF3 and apuf3 deletion. In the 
wild-type PAB1 PUF3 strain, the COXl 7 poly(A) tail reached the oligo(A) form by five 
minutes, and by fifteen minutes there was almost no transcript remaining (Figure 9A), 
indicating that mRNA decapping and degradation had taken place. In contrast, in the 
Xpuf3 background, which is known to display slowed deadenylation of the COXl 7 
poly(A) tail (Olivas and Parker, 2000), deadenylation was slowed and the oligo(A) form 
did not appear until 15 to 20 minutes (Figure 9C). Furthermore, in the PUF3 background, 
at 30 minutes there is still a significant amount of COXl 7 mRNA present (Figure 9C), 
which is indicative of slowed decapping, as previously observed (Olivas and Parker, 
2000). These results reflect what has been previously shown about the effect of PUF3 on 
COXl 7 (Olivas and Parker, 2000), and indicate that this analysis is suitable for 
determining any PAB1 effects on COXl 7 deadenylation.
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Figure 9 -  Deadenylation assay of COXl 7 in wild-type PAB1 background. One sample 
was hybridized to an oligo-thymidine (dT) in order to identify the fully deadenylated 
species. Small cytoplasmic RNA 1 (SCR1) is used as a loading control. (A) Wild-type 
PUF3. (B and D) Average poly(A) tail length as a function of time after transcription 
shut off as depicted in panel A and panel C, respectively. (C) Apu/3.
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The PAB1 RRM1 Domain is Necessary for Deadenylation of COXl 7
Previous analysis has shown that deletion of the RRM1 domain in PAB1 slows 
deadenylation of GALI and MFA2 mRNA but does not stop it completely (Yao et al., 
2007). If PUF3 does not specifically interact with the mRNP complex or PAB1, then 
COXl 7 should behave the same as GALI and MFA2 in respect to an RRM1 deletion. 
Moreover, if the deadenylation mechanism that PAB1 RRM1 works through is the same 
for all mRNA, then MFA2 and COXl 7 should show similar deadenylation rates relative 
to the wild-type PAB1. In a strain with a PAB1 RRM1 deletion, COXl 7 showed 
extremely slow deadenylation (Figures 10A, C), in both wild type PUF3 and the puf3 
deletion, COXl 7 poly(A) tail lengths were only marginally shorter in the 30 minute time 
point compared with the zero minute time point. Compared to the deadenylation rate of 
GALI and MFA2 (Figures 11, 12 - Yao et al., 2007), the PAB1-ARRM1 variant showed a 
block in deadenylation more severe for COXl 7. This observation indicates that the 
RRM1 domain of PAB 1 is absolutely required for deadenylation of the COXl 7 poly(A) 
tail.
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Figure 10 -  Deadenylation assay of COXl 7 in a PAB1-ARRM1 background. One sample 
was hybridized to an oligo-thymidine (dT) in order to identify the fully deadenylated 
species. Small cytoplasmic RNA 1 (SCR1) is used as a loading control. (A) Wild-type 
PUF3. (B and D) Average poly(A) tail length as a function of time after transcription 
shut off as depicted in panel A and panel C, respectively. (C) Apuf3. experiments.
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Figure 11 -  Summary of GAL1 deadenylation rates conducted by Gang Yao, and 
published as supplementary figures (Yao et al., 2007). PAB1-ARRM1 and PAB1-AP 
deadenylation rates are much slower compared to wild-type and PAB1-ARRM3. 
Deadenylation in PAB1-ARRM1 and PAB1-AP is blocked as is shown in a Acer4 
background.
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Figure 12 - Summary of MFA2 deadenylation rates conducted by Gang Yao, and 
published as supplementary figures (Yao et al., 2007). PAB1-ARRM1 and PAB1-AP 
deadenylation rates are much slower compared to wild-type and PAB1-ARRM3. 
Deadenylation in PAB1-ARRM1 and PAB1-AP is blocked as is shown in a Acer4 
background.
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The Effect of PAB1 RRM2 on COX17
Previous analysis of PAB1-ARRM2 showed a slower deadenylation rate for both 
MFA2 and GAL1 (Yao et al., 2007). The deadenylation rate of MFA2 and GAL I in 
PAB1-ARRM2 was not as slow as observed for the two domain deletions resulting in the 
slowest deadenylation rates, PAB1-ARRM1 and PAB1-AP, but was slower compared to 
wild-type. My analysis of COX17 in a PAB1-ARRM2 background also showed a slower 
deadenylation rate with wild-type PUF3 and a lesion inpuf3 (Figures 13 A, B, C, D), but 
not as slow as in a PAB1-ARRM1 background (Figure 10A, B). It has been shown that 
deletion of the RRM2 domain in PAB1 causes destabilization of the CCR4-NOT 
complex, resulting in about a four-fold reduction in CCR4 abundance in the cell (Yao et 
al., 2007). Since the CCR4-NOT complex is responsible for the majority of 
deadenylation of mRNA (Tucker et al., 2001), this explains the slower deadenylation 
rates for GAL1, MFA2, and COX17 in a PAB1-ARRM2 background compared to wild- 
type (Yao et al., 2007; Figures 9A, B). Additionally, this suggests that the PAB1 RRM2 
domain plays the same role in deadenylation for mRNA dependent and independent on 
PUF3 for accelerating deadenylation.
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Figure 13 -  Deadenylation assay of COX17 in a PAB1-ARRM2 background. One sample 
was hybridized to an oligo-thymidine (dT) in order to identify the fully deadenylated 
species. Small cytoplasmic RNA 1 (SCR1) is used as a loading control. (A) Wild-type 
PUF3. (B and D) Average poly(A) tail length as a function of time after transcription 
shut off as depicted in panel A and panel C, respectively. (C) Apuf3.
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The Effect of PAB1 RRM3 on COX17
Deletion of the RRM3 domain in PAB1 was shown to accelerate the 
deadenylation rates of MFA2 and GAL1 mRNA (Yao et al., 2007). The COX17 transcript 
in PAB1-ARRM3 with wild-type PUF3 showed that the poly(A) tail was completely 
deadenylated by five minutes (Figure 14A), which in wild-type PAB1, COX17 mRNA 
became nearly completely deadenylated by this time point. Although COX17 poly(A) 
tail length at the five minute time point is the same for both wild-type PAB1 and PAB1- 
&RRM3, the poly(A) tail length at the zero minute time point is much shorter in the 
PAB1-IS.RRM3 background (-12 A’s, Figure 14B) compared to the wild-type PAB1 
background (-28 A’s, Figure 9B). In addition, COX17 mRNA is nearly gone by ten 
minutes in an RRM3 deletion background in contrast to 15 minutes for wild-type. These 
results suggest that deleting the RRM3 domain in PAB1 accelerates deadenylation in a 
PUF3 background.
In the Apuf3 background, the PAB1 RRM3 deletion also accelerated COX17 
deadenylation (Figure 14C). The COX17 mRNA does not completely deadenylate in a 
puf3 deletion with wild-type PAB1 (Figure 9C) whereas a fully deadenylated COX17 
mRNA was observed at the fifteen minute time point in a PAB1-A.RRM3 background, 
despite the absence ofpuf3 (Figure 14C). This indicates that the mechanism whereby 
PAB1-ARRM3 accelerates deadenylation is a general mechanism that works on mRNA 
independent and dependent on PUF3.
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Figure 14 -  Deadenylation assay of COX17 in a PAB1-ARRM3 background. One sample 
was hybridized to an oligo-thymidine (dT) in order to identify the fully deadenylated 
species. Small cytoplasmic RNA 1 (SCR1) is used as a loading control. (A) Wild-type 
PUF3. (B and D) Average poly(A) tail length as a function of time after transcription 
shut off as depicted in panel A and panel C, respectively. (C) Apuf3.
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The Effect of PAB1 RR.M4 on COX17
Previous analysis of PAB1-ARRM4 showed no change in the deadenylation of 
MFA2 and GAL1 mRNA compared to wild-type (Yao et al., 2007). Analysis of COX17 
mRNA showed a poly(A) tail length of zero A’s by five minutes in a PAB1-ARRM4 
background (Figure 15A), which is similar to wild-type (Figure 9A). The double mutant, 
PAB1-ARRM4 Apuf3, displayed a slightly slower deadenylation rate compared to Apuf3 
alone (Figures 15D and 9D). In the Apu/3 alone, the poly(A) tail length of COX17 is 
deadenylated to a length of 8-10 A’s by fifteen minutes and remains at that length for the 
remaining time points (Figure 9C). In comparison, the double mutant, PAB1-ARRM4 
Apu/3, showed the COX17 transcript deadenylated to the same length as the Apu/3 alone, 
8-10 A’s, by twenty minutes (Figure 15C). These observations suggest that the RRM4 
domain of PAB1 is at least partially responsible for proper deadenylation of PUF3 
dependent transcripts when PUF3 is absent.
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Figure 15 -  Deadenylation assay of COX17 in a PAB1-ARRM4 background. One sample 
was hybridized to an oligo-thymidine (dT) in order to identify the fully deadenylated 
species. Small cytoplasmic RNA 1 (SCR1) is used as a loading control. (A) Wild-type 
PUF3. (B and D) Average poly(A) tail length as a function of time after transcription 
shut off as depicted in panel A and panel C, respectively. (C) Apuf3.
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PAB1 P Domain is not Necessary for Deadenylation of COX17
In a deletion of the P domain of PAB1, GAL1 and MFA2 showed an extreme 
deficiency in deadenylation (Figures 11, 12 - Yao et al., 2007). In contrast with GAL1 
and MFA2 deadenylation data, the PAB1-AP variant showed almost complete 
deadenylation of COX17 by ten minutes and no visible mRNA by fifteen minutes (Figure 
16A). The PAB1-AP puf3A strain showed a block in deadenylation more severe than the 
PAB1 puf3A strain (Figure 16C), after 30 minutes deadenylation remained completely 
blocked in the PAB1-AP puf3A strain. This observation indicates that the block in 
deadenylation observed by a PAB1 P deletion is bypassed by PUF3, and that deletion of 
both PUF3 and the PAB1 P  domain severely impairs deadenylation.
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Figure 16 -  Deadenylation assay of COX17 in a PAB1-&P background. One sample was 
hybridized to an oligo-thymidine (dT) in order to identify the fully deadenylated species. 
Small cytoplasmic RNA 1 (SCR1) is used as a loading control. (A) Wild-type PUF3. (B 
and D) Average poly(A) tail length as a function of time after transcription shut off as 
depicted in panel A and panel C, respectively. (C) Apuf3.
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The Effect of PAB1 C on COX17
Analysis of MFA2 and GAL1 in PAB1-AC showed a slight decrease in the rate of 
deadenylation (Yao et al., 2007). The translation termination factor eRF3 and PAN2/3 
complex are two proteins that contact the C terminal domain of PAB1 (Mangus et al., 
1998; Hosoda et al., 2003; Kobayashi et al., 2004). Since eRF3 and deadenylation has 
been shown to be linked (Hosoda et al., 2003; Kobayashi et al., 2004) and PAN2 is a 
known deadenylase, it is likely that the role of the C terminal domain in PAB1 is a 
general one that affects all or most mRNA. In the PAB1-AC background the 
deadenylation rate of COX17 is slightly slower (Figure 17A) compared to wild-type 
PAB1 (Figure 9A) and when puf3 is deleted in the FAB 1-AC variant (Figure 17C) the 
deadenylation rate is much slower compared to the wild-type PAB1 Apuf3 strain (Figure 
9C). By ten minutes the COX17 poly(A) tail length has reached zero A ’s in wild-type 
PAB1 (Figure 9A) and in the PAB1-AC variant at ten minutes there is still COX17 mRNA 
present (Figure 17 A), indicating that deletion of the C domain in PAB1 slows 
deadenylation slightly. The COX17 poly(A) tail length in the double mutant, PAB1-AC 
Apu/3, was deadenylated to a length of approximately 20 A’s by the fifteen minute time 
point (Figures 17C, D) and remained at a length of approximately 20A’s until the last 
time point was taken at thirty minutes, which is twice as long as the terminal poly(A) tail 
length of COX17 in the wild-type PAB1 Apu/3 strain (Figure 9C, D). This indicates that 
COX17 mRNA shows a similar decrease in the deadenylation rate as MFA2 and GAL1, 
which suggests that the C terminal domain of PAB1 plays a PUF3-independent role in 
deadenylation.
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Figure 17 -  Deadenylation assay of COX17 in PAB1-AC background. One sample was 
hybridized to an oligo-thymidine (dT) in order to identify the fully deadenylated species. 
Small cytoplasmic RNA 1 (SCR1) is used as a loading control. (A) Wild-type PUF3. (B 
and D) Average poly(A) tail length as a function of time after transcription shut off as 
depicted in panel A and panel C, respectively. (C) Apuf3.
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Decapping of COX17 is not Affected by PAB1 Deletions
In the major mRNA degradation pathway, deadenylation is the initial step, 
followed by decapping and degradation of the mRNA body. Since decapping can be 
inhibited by PAB1 (Morrissey et al., 1999; Caponigro and Parker, 1995), it is possible 
that mutations in PAB1 have an effect on decapping and eventual degradation of the 
mRNA. If a decapping defect is present then two events could occur. First, mRNA 
degradation could be blocked despite deadenylation of the poly(A) tail. Second, mRNA 
degradation could occur independently of deadenylation. The first event would be 
observed if COX17 mRNA does not degrade following deadenylation. A wild type PUF3 
background accelerates COX17 deadenylation in the following PAB1 domain deletions: 
PAB1-ARRM2, PAB1-ARRM3, PAB1-ARRM4, PAB1-AP, and PAB1-AC (Figures 13A, 
14A, 15A, 16A, 17A), and since COX17 mRNA has degraded following deadenylation, 
none of these PAB1 domain deletions caused a defect in decapping. Furthermore, when 
COX17 deadenylation is blocked as observed in PAB1-ARRM1 we do not see any COX17 
mRNA being degraded (Figure 1OA). This last observation does not support the second 
event, that mRNA degradation could occur independently of deadenylation.
A puf3 deletion is known to block COX17 mRNA decapping. This can be 
observed in Figure 9C in which COX17 mRNA does not become degraded after the oligo 
(A) form of COX17 is reached at about 15 minutes. None of the PAB1 variants that I 
analyzed bypassed this affect of pu/3A on the decapping of COX17. These observations 
indicate that the analyzed PAB1 domain deletions do have a role in deadenylation but not 
in decapping.
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The decapping step has been shown to occur in discrete locations in the 
cytoplasm, labeled P bodies (Sheth and Parker, 2003). PAB1 and the deadenylases have 
been shown to localize to the cytoplasm (Sheth and Parker, 2003), suggesting that 
deadenylation occurs in the cytoplasm and the deadenylated mRNA then moves to P 
bodies where decapping and further degradation occurs. Since deadenylation occurs in a 
puf3 deletion but degradation does not occur (Figures 9C, 10C, 13-17C) it is likely that 
PUF3 has a role in the degradation and possibly decapping of COX17 mRNA. Because 
PUF3 is localized in the cytoplasm (Sheth and Parker, 2003), while PUF3 itself does not 
localize to P bodies (Sheth and Parker, 2003) it is possible that PUF3 is involved in the 
transport of COX17 mRNA from the cytoplasm to P bodies. This could be easily 
observed by examining the localization of COX17 mRNA. A GFP-MS2 fusion has been 
shown allow visualization of an mRNA containing a MS2 binding site within the 
transcript (Sheth and Parker, 2003). Determination of the localization of COX17 in 
PUF3 and Apuf3 strains could be accomplished by examining if PUF3 has a role in the 
transportation of COX17-MS2 from the cytoplasm to P bodies.
The Effect of eIF4E on COX17
A defect in the cap binding protein, eIF4E, was shown to accelerate the 
deadenylation rate of the stable mRNA, PGK1, which has an average half-life of 17 
minutes in a wild-type background (Schwartz and Parker, 1999). The unstable mRNA, 
MFA2, which has a half-life of 3.5 minutes, did not show an accelerated deadenylation 
rate when a defect in eIF4E was present (Schwartz and Parker, 1999). The first 
observation indicates that wild-type eIF4E slows deadenylation by some unknown 
mechanism. The second observation could be explained by three possibilities. First, the
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deadenylation mechanism that eIF4E acts on does not affect MFA2. The second 
possibility is that the deadenylation rate of MFA2 is so fast that the deadenylation 
mechanism that eIF4E acts on does not affect MFA2 or any mRNA with a fast 
deadenylation rate. Third, the defect in eIF4E does accelerate the deadenylation rate, but 
the change is undetectable by this assay.
Our previous results showed that PUF3 is capable of co-immunoprecipitation of 
eIF4E (Y.C. Chiang, personal communication). If PUF3 makes contact with eIF4E or 
another translation initiation factor to mediate deadenylation then a defect in eIF4E 
should show a change in the deadenylation rate of COX17. Since it has been shown that 
a defect in eIF4E is capable of accelerating the rate of deadenylation for GAL1 and PGK1 
(T. Ohn, personal communication; Schwartz and Parker, 1999), we would expect that 
deadenylation of COX17 would be accelerated as well. In order to test if the eIF4E 
defect affects deadenylation of COX17 ,1 analyzed the COX17 deadenylation rate in a 
strain carrying the cdc23-l allele, which encodes a temperature sensitive eIF4E protein. 
The cdc33-l allele, at 37°C, did not cause a significant increase in the deadenylation rate 
compared to the wild-type strain at 37°C (Figure 18A, 19A), and both wild-type and 
cdc33-l strains showed oligo-adenylated poly(A) tail length by two minutes and the 
COX17 mRNA was gone by five minutes (Figure 18 A, 19A). This observation is similar 
to what was observed for MFA2 (Schwartz and Parker, 1999) and the same three 
possibilities apply. It is possible that the mechanism whereby eIF4E accelerates 
deadenylation does not work on COX17. However, since both COX17 and MFA2 are 
both very unstable mRNA, it is likely that the mechanism that eIF4E works through is
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just not apparent for these two mRNA, as the deadenylation rate is already so fast that a 
defect in eIF4E would not accelerate it even further.
If the mechanism whereby eIF4E works to accelerate deadenylation is a general 
mechanism affecting all mRNA, then deadenylation of COX17 in a puf3 deletion 
background should be accelerated as well. Analysis of the double mutant, cdc33-l 
Apuf3, showed deadenylation of COX17 stop at ten minutes (Figures 19B, D), which is 
the same time point when deadenylation of COX17 stopped in the strain carrying the 
lesion inpuf3 alone at 37°C (Figure 18B, D). The difference in poly(A) tail length may 
be due to decapping occurring much faster due to the defect in eIF4E, which has been 
observed previously to inhibit the decapping reaction (Schwartz and Parker, 1999; 
Schwartz et al., 2003). A defect in eIF4E does appear to affect the final length of the 
COX17 poly(A) tail ifpuf3 is absent (Figures 18B, 18D, 19B, 19D), so it is likely that 
eIF4E does affect COX17 mRNA. However, these observations indicate that PUF3 is 
required to accelerate deadenylation of COX17, despite the defect in eIF4E (Figures 19A, 
B, C, D). This indicates that the mechanism that PUF3 acts through, is downstream of 
the mechanism that eIF4E works through.
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Figure 18 -  Deadenylation of COX17 at 37°C. Assay was conducted at 37°C, as a control 
for the cdc33-l allele. One sample was hybridized to an oligo-thymidine (dT) in order to 
identify the fully deadenylated species. Small cytoplasmic RNA 1 (SCR1) is used as a 
loading control. (A) Wild-type PUF3. (B and D) Average poly(A) tail length as a 
function of time after transcription shut off as depicted in panel A and panel C, 
respectively. (C) tspuf3.
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Figure 19 -  Deadenylation assay of COX17 in PAB1-WTcdc33-l background. Assay 
was conducted at 37°C, the non-permissive temperature for the cdc33-l allele. One 
sample was hybridized to an oligo-thymidine (dT) in order to identify the fully 
deadenylated species. Small cytoplasmic RNA 1 (SCR1) is used as a loading control. (A) 
Wild-type PUF3. (B and D) Average poly(A) tail length as a function of time after 
transcription shut off as depicted in panel A and panel C, respectively. (C) Apuf3.
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Strain Relevant Genotype Rate (A's/min) t for 0 As SEM Total Samples
319/504 PAB1-WT 5.4 5 0.3 4
319/505 PAB1-ARRM1 0.5 >30 0 4
319/506 PAB1-ARRM2 1.4 20-30 0.3 2
319/507 PAB1-ARRM3 3.5 5 0.6 2
319/508 PAB1-ARRM4 5.3 10 1 3
319/510 PAB1-AC 3.1 10 0.2 5
319/509 PAB1-AP 5.7 5 0.3 3
319/504 37°C PAB1-WT 37°C 4.7 5 0.4 3
1881/504 cdc33-1 1.7 5 0.4 2
1738/504 PAB1-WT Apuf3 0.9 30 0.2 4
1738/505 PAB1-ARRM1 Apuf3 0.4 >30 0 3
1738/506 PAB1-ARRM2 Apuf3 0.6 >30 0.1 2
1738/507 PAB1-ARRM3 Apuf3 0.5 15 0.1 2
1738/508 PAB1-ARRM4 Apuf3 1 20 0 3
1738/510 PAB1-AC Apuf3 0.6 >30 0 4
17.8/509 PAB1-AP Apuf3 0.7 >30 0 3
1738/504 37°C PAB1-WT Apuf3 37°C 1.3 10 0.1 2
1777/504 cdc33-1 Apuf3 0.4 >30 0.1 2
Table 9 -  Summary table of COX17 deadenylation rates. SEM is the standard error of 
the mean of the rate, calculated by dividing the standard deviation by the square root of 
the total number of samples. For strains with a very fast deadenylation rate it was 
difficult to obtain a precise measure of the true deadenylation rate. In order to analyze 
the deadenylation rate, a qualitative approach was used. The qualitative approach that I 
used was to describe at what time point the COX17 poly(A) tail was fully deadenylated as 
indicated by “t for 0 A’s”.
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Discussion
This data provides three observations supporting the model that PUF3 interacts 
with components of the mRNP complex for proper deadenylation. First, the RRM1 
domain of PAB1 is required for deadenylation of COX17 (Yao et al., 2007). Second, 
PUF3 is able to bypass the requirement of the P domain in PAB1, which was shown to be 
required for deadenylation of MFA2 and GAL1 (Yao et al., 2007). Third, we have also 
shown that PUF3 co-immunoprecipitates multiple components of the CCR4-NOT 
complex (Y. Chiang, personal communication), and COX17 requires CAF1, CCR4, and 
PAN2 for deadenylation (Tucker et al., 2002). These observations suggest that PUF3 
works to simultaneously perturb the mRNP complex and recruit deadenylases.
Although this data shows an interaction between PAB1 and PUF3, the exact 
mechanism whereby PUF3 communicates with PAB1 is still a mystery. Since PUF3 did 
not co-immunoprecipitate PAB1 (data not shown), nor did apoly(A) sepharose pull­
down identify PUF3 (G. Quigley, personal communication), it is likely that PUF3 makes 
unknown proteins contacts which are responsible for PAB1 contacts. In Drosophila, 
Pumilio contacts Nanos and Brat to repress hunchback mRNA (Edwards et al., 2001; 
Wang et al., 2002; Wang et al., 2001; Edwards et al., 2003). This observation, supports 
the model that PUF3 in Saccharomyces could function in a similar manner by contacting 
additional proteins that are responsible for contacting PAB1.
Since eIF4E did co-immunoprecipitate with PUF3, it is possible that some sort of 
communication between PUF3 and PAB1 is mediated through the cap-binding protein.
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In order to show that PUF3 does in fact contact eIF4E, the pull down would need to be 
conducted in the presence of RNaseA to rule out RNA contacts. If the eIF4E and PUF3 
contact is RNA independent then a yeast two-hybrid experiment, or an in vitro binding 
experiment could be used to show that the two proteins do in fact interact. Additionally, 
to show that eIF4E does act on PUF3 controlled mRNA, a mRNA with a slower 
deadenylation rate would need to be used to show that a defect in eIF4E does in fact 
accelerate deadenylation of a PUF3 controlled mRNA. CYT2 or TUF1 have recently 
been shown to be controlled by PUF3 (Olivas W, poster #380, RNA meeting 2007). 
These mRNA would be suitable candidates to show that a defect in eIF4E does accelerate 
deadenylation of PUF3 controlled mRNA. Alternatively, a chimeric GAL1-COX17 3’ 
UTR could be used for further analysis. This could be used to show that the PUF3 
consensus sequence is sufficient to accelerate deadenylation of a non-PUF3 controlled 
mRNA. If the chimeric reporter has a slower deadenylation rate then we could analyze 
the mRNA in a cdc33-l background, which could show more definitively that a defect in 
eIF4E does or does not require PUF3 to accelerate deadenylation.
This work and previous work has shown that the various PAB1 domains each 
play different roles in deadenylation. It is likely that since the RRM2, RRM3, and C 
domains in PAB1 act on general mechanisms that they affect all mRNA, or at the very 
least that they affect both PUF3-dependent and PUF3-independent transcripts. The P 
domain in PAB1 is necessary for proper deadenylation of transcripts that do not require 
PUF3. The requirement for this domain in COX17 deadenylation was bypassed by the 
PUF3 protein to allow rapid deadenylation and degradation of the COX17 mRNA. PUF3 
and the P domain function may act through a similar mechanism in the deadenylation of
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transcripts. This work has shown that the PAB1 RRM1 domain is absolutely necessary 
for deadenylation of COX17, indicating that PUF3 somehow works through PAB1 RRM1 
in some way to accelerate deadenylation. Although further work is necessary to 
definitively prove that eIF4E requires PUF3 for proper deadenylation, these results 
suggest that PUF3 works downstream of eIF4E in the deadenylation process.
This work provides support for the model that PUF3 does in fact work through the 
mRNP complex to accomplish deadenylation of its target transcripts. Our studies and 
those of others have also provided evidence that PUF proteins recruit deadenylases to the 
target transcript, suggesting that PUF proteins both recruit and perturb the mRNP 
complex to accomplish deadenylation and eventual degradation of the transcript.
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GENERAL DISCUSSION
In this work I have investigated the biological roles of the mRNP complex, 
focusing specifically on the poly(A) binding protein (PAB1) and its role in mRNA 
deadenylation. The two processes that I have examined are: the relationship of to mRNA 
deadenylation and the role of PAB1 in controlling regulated mRNA deadenyaltion.
The in vivo translation analysis of PAB1 was conducted for two reasons. First, in 
vivo translation rates were measured in each of the PAB1 variants to determine which, if 
any of the domains have a role in translation in vivo. The second reason for this analysis 
is to determine if any of the PAB1 domains have pleiotropic effects, specifically on 
translation and deadenylation. It has been shown that translation and mRNA degradation 
are linked (Schwartz and Parker, 1999), and it is also known that PAB1 plays a role in 
both translation (Sachs and Deardorff, 1992; Otero et al., 1999; Gray et al., 2000) and 
mRNA deadenylation (Tucker et al., 2002; Wilusz et al., 2001; Caponigro and Parker, 
1995). Hence, a defect that a PAB1 variant may have on mRNA deadenylation could 
also cause a defect in translation or a defect in translation could cause a defect in 
deadenylation.
The first conclusion of the in vivo translation analysis is that individual domains 
of PAB1 do not have a major role in translation. Because none of the PAB1 variants 
displayed a decrease in translation rate as severe as defects in known translation initiation 
components, such as eIF3 or eIF4E (Figure 4, Table 3), this analysis suggests that PAB1 
has a minor role in translation. However, the minor role that PAB1 does play in 
translation appears to be mediated by the RRM1 and RRM2 domains. Of the PAB1
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domain deletions, only deleting RRM1 and RRM2 showed a significant decrease in the 
rate of in vivo translation (Figure 5, Table 4), suggesting that only two of the six domains 
are involved in translation. Previous experiments support this observation. Analysis of 
PAB1 domains capable of translational stimulation showed that only domains RRM1 and 
RRM2 were sufficient to stimulate translation (Gray et al., 2000). Since PAB1 lethality 
can be rescued by RRM1/2 but not other domains, these observations suggest that the 
PAB1 translational role of RRM1/2 is important. But since individual deletions of PAB1 
RRM1 and RRM2 had a minor effect on translation, it is likely that the PAB1 RRM1 and 
RRM2 domains do not have direct roles in translation, and appear to support the function 
of additional factors.
Analysis of the PAB1 variants in combination with other factors indicates that 
PAB1 RRM2 has roles in translation related to eIF4E and eIF3. eIF4E and eIF3 are 
involved in different aspects of translation initiation, suggesting that PAB1 is involved in 
different processes of translation. These observations do not indicate a definitive 
mechanism for PAB1 involvement in translation but does indicate that PAB1 does in fact 
play multiple roles. Additionally, this data confirms previous in vitro experiments which 
indicate PAB1 RRM2 plays a key role in translation (Kessler and Sachs, 1998; Otero et 
al., 1999).
My work provides additional evidence linking translation and deadenylation. 
CAF1 involvement in deadenylation is known (Tucker et al., 2002), albeit, in a partially 
separate role from the major deadenylase, CCR4 (Ohn et al., 2007). My analysis has 
confirmed that CAF1 has a role in translation and that role is more important and 
different from CCR4 (Figure 8, Table 7). The evidence suggesting that CAF1 and CCR4
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have separate roles in translation is supported by the observation that a lesion in cafl 
caused a greater defect in translation combined with the PAB1-184 variant, whereas a 
lesion in ccr4 caused a greater defect in translation when combined with the PAB1-134 
variant (Figure 8). Because a deletion of cafl has a greater defect on translation with 
PAB1-184, whereas a deletion of cc.r4 did not, it is likely that CAF1 is involved in the 
mechanism that PAB1-184 participates in, whereas CCR4 is involved in a similar 
mechanism as PAB1-134. PAB1-184 functions to aid eIF4G contact to PAB1 and in vitro 
it blocks translation. PAB1-134 in contrast, destabilizes the mechanism of translation 
initiation that eIF3 is involved in. This indicates that PAB1 is involved in translation and 
that involvement requires many additional factors. Furthermore, because defects in 
PAB1 alone do not cause major defects in translation, and a large decrease in translation 
is observed when PAB1 variants are combined with other defects, this suggest that PAB1 
may not have a direct role in translation. Instead, PAB1 may merely serve as a scaffold 
for the translation initiation factors to assemble on. More specifically, the PAB1 RRM1 
and RRM2 domains are the location for the translation initiation factors to bind.
In the second part of my thesis, I analyzed the effect of PAB 1 defects on on the 
PUF3 regulated deadenylation of COX17. Transcriptional pulse-chase analysis of PAB 1 
domain deletions, displayed a decreased deadenylation rate for GAL1, MFA2, and COX17 
in PAB1-ARRM2 and PAB1-AC backgrounds (Yao et al., 2007; Figures 13A, B, 17A, B; 
Table 9), whereas, aPABl-ARRM3 background displayed an accelerated deadenylation 
rate (Yao et al., 2007; Figure 14A, B; Table 9). These observations suggest that PAB1 
acts positively and negatively on deadenylation, multiple PAB1 domains are involved in 
deadenylation, and these domains act through mechanisms that are similar for PUF3
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dependent and independent mRNA. The most severe deadenylation defect of GAL1 and 
MFA2 was in PAB1-ARRM1 and PAB1-AP backgrounds (Figure 11, 12 - Yao et al.,
2007). These domains have also been shown to be important for PAB1 self association 
(circular form) and formation of PAB1 multimers. More importantly, these self­
associated PAB1 species bind poly(A) less efficiently than single, linear PAB1 (Yao et 
al., 2007). This suggests that formation of circular PAB1 causes dissociation of PAB1 
from the poly(A) tail, which stimulates deadenylation (Figure 20A). Because deletion of 
the RRM1 domain caused the most severe deadenylation defect of GAL1, MFA2, and 
COX17 (Figures 11, 12 - Yao et al., 2007; Figure 10A, B; Table 9) it is likely that this 
domain is the most crucial for the PAB1 role in deadenylation. A likely model is that 
PAB1 RRM1 is responsible for PAB1 dissociation and binding of poly(A). Since 
roughly equivalent amounts of circular and linear PAB1 have been observed (Yao et al., 
2007), it is likely that the disassociated PAB1 (circular) and bound PAB1 (linear) are in 
equilibrium. In order for rapid deadenylation to occur, some sort of stabilizing 
mechanism is necessary to maintain the PAB1 circular form.
In addition to the PAB1 RRM1 domain, the P domain in PAB1 is also necessary 
for formation of the PAB1 circular species. This suggests that the PAB1 P domain is 
necessary for formation of circular PAB1, and therefore would be necessary for 
deadenylation. It has been demonstrated that the PAB1 P domain is necessary for 
deadenylation of GAL1 and MFA2 but not COX17 (Figures 11,12 - Yao et al., 2007; 
Figure 16A, B; Table 9). Since PUF3 is involved in deadenylation of COX17, it is likely 
that PUF3 bypasses the requirement of the PAB1 P domain. If the PAB1 P domain is 
acting to promote formation of circular PAB1 then PUF3 must also promote formation of
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circular PAB1. Since is has not been show that PUF3 contacts PAB1 (G. Quigley, 
personal communication; results not shown), it is likely that PUF3 contacts another 
protein which is responsible for contacting and stabilizing the circular form of PAB1.
Several observations suggest that eIF4E and other TIFs are involved in preventing 
formation of circular PAB1. The first observation is that eIF4E co-immunoprecipates 
with PUF3. Second, PAB1-ARRM2 can still interact with TIFs (Y. Chiang, personal 
communication). Since PAB1 RRM2 is known to contact eIF4G, which in turn binds 
eIF4E, these results imply that the TIFs are making contact to other domains of PAB1, 
such as to RRM1. Third, deleting the RRM1 domain reduces by two to three fold the 
amount of eIF4G associated with PAB1, which suggests that eIF4E contacts PAB1 
through contacts in addition to the RRM2 domain of PAB1. This suggests that PUF3 
could contact PAB1 through eIF4E. Fourth, a defect in eIF4E caused accelerated 
deadenylation of GAL1 and PGK1 (Schwartz and Parker, 1999; T. Ohn, personal 
communication). This suggests that the TIF complex blocks or slows deadenylation, 
perhaps by inhibiting the formation of the circular PAB1. One model that incorporates 
these observations is that eIF4G contacts PAB1 through the RRM1 domain to prevent 
PAB1 from circularizing and dissociating from poly(A). In this model, dissociation of 
PAB1 from poly(A) occurs through circularization of PAB1, which happens freely and is 
the favored structure, but, eIF4G, or any TIFs, contact to PAB1 prevents circularization. 
Through binding of the PAB1 P domain or PUF3 to eIF4E/eIF4G/eIF4A the connection 
between PAB1 and the TIFs is broken or diminished, thus allowing for more circular 
PAB1 and making the poly(A) to be more accessible to CCR4 (Figure 20B).
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Figure 20A -  Model for PAB1 self-association and disassociation from poly(A). TIFs 
contact PAB1 RRM1, which prevents PAB1 circularization. The PAB1 P domain 














Figure 20B -  Competition model for PUF3 mediated mRNP disruption. PUF3 plays a 
similar role as the PAB1 P domain. PUF3 contacts the TIFs to reduce TIF contact with 
the PAB1 RRM1 domain, thus favoring circularization of PAB1 and dissociation of 
PAB1 frompoly(A).













Figure 20C -  Alternative competition model for PUF3 mediated mRNP disruption. 
Instead of PUF3 contacting the TIFs which contact PAB1, PUF3 contacts an unknown 
protein which contacts PAB1.
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Obviously, more work needs to be done to support this model. If TIFs are 
responsible for inhibiting formation of circular PAB1, the amount of circular PAB1 
should be higher in a cdc33-l background compared to wild-type. This could be shown 
by comparing the relative abundance of the circular form in a cdc33-l background versus 
a wild-type.
In order to prove the competition model, whereby the P domain of PAB1 or PUF3 
competes with PAB1 RRM1 for TIF binding, three observations would need to be 
confirmed. First, it must be shown that PUF3 contacts TIFs directly, which could be 
done through in vitro binding assays. Second, it must be shown that addition of PUF3 
disrupts or diminishes the TIF PAB1 contact. If the first observation is correct, then this 
could be done by adding PUF3 to purified eIF4G and purified PAB1, and determining if 
less eIF4G binds to PAB1. Third, contact between eIF4G and PAB1 must be completely 
disrupted and shown that this contact has a role in formation of circular P AB1 and 
accelerates deadenylation. Since PAB1-180 and PAB1-184 have been shown to contact 
eIF4G (Otero et al., 1999), a combination of these two mutations must be analyzed. 
Alternatively, the CAF20 protein is known to compete with eIF4G for eIF4E (Altmann et 
al., 1997; Ptushkina et al., 1998). Over-expression of CAF20 could therefore be used to 
disrupt the eIF4E contact to PAB1.
If it cannot be demonstrated that PUF3 communicates with PAB1 through the 
TIFs, it is possible that another protein mediates the connection (Figure 20C). It is 
possible that an unknown protein (not a TIF) contacts PUF3 which in turn contacts PAB1 
to promote circularization and dissociation from the poly(A) tail. This hypothetical 
protein could be identified through PUF3 purification and mass spec analysis of
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associated proteins. An alternative method would be through a two-hybrid screen for 
proteins that interact with PUF3. Since this protein would need to contact PAB1, likely 
candidates would be proteins that contact PUF3 who are known to also contact PAB1.
This work shows that PAB1 has multiple roles, both in deadenylation and 
translation. Two observations suggest it is likely that PAB1 has a larger role on 
deadenylation than translation. First, every PAB1 domain, except RRM4, had an effect 
on deadenylation, whereas, only RRM1 and RRM2 had an effect on translation. Second, 
PAB1 variants did not show a decrease in translation rate comparable to the decrease in 
translation associated with a defect in eIF4E or eIF3. These observations support the 
hypothesis that PAB1 has a larger role in deadenylation than in translation. In addition 
this work shows that the role of PAB1 in deadenylation is both general and specific for 
PUF3 controlled mRNA.
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